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are provided. In some embodiments, the methods may be 
used to determine the location or positioning of a metal object 
in a sample. In other embodiments, the methods may be used 
to determine the composition of a sample Surrounding a metal 
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COMBINED ULTRASOUND AND 
PHOTOACOUSTIC MAGING OF METAL 
OBJECTS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application claims the benefit of U.S. Provisional 
Patent Application Ser. Nos. 61/394,642 filed Oct. 19, 2010 
and 61/435,474, filed Jan. 24, 2011, and is a continuation-in 
part of U.S. patent application Ser. No. 13/190,334, filed Jul. 
25, 2011, the entire disclosures of which are incorporated by 
reference. 
STATEMENT OF GOVERNMENT INTEREST 
This invention was made with government Support under 
Grant Number HL096.981 awarded by the National Institutes 
of Health. The government has certain rights in the invention. 
BACKGROUND 
A wide variety of metal implants are used clinically within 
the human body. These range from permanently implanted 
metals such as orthopedic replacements, coronary arterial 
stents, or brachytherapy seeds, and include temporarily 
implanted metals such as Surgical staples. 
Hypodermic needles are one such temporary metal implant 
used for a wide variety of clinical applications. Metal needles 
are commonly used for localized drug delivery, Such as in 
cancer therapy, or for tissue collection in biopsy. In either 
case, the ability to visualize both the anatomical surrounding 
structures and the advancing needle tip is required. Several 
procedures, such as drug delivery, tissue biopsy collection, or 
brachytherapy seed placement, all require accurate injection 
of a metal needle. Needle tracking also requires the visual 
ization of the tissue background so that specific tissue land 
marks such as tumors or lesions may be targeted or avoided 
when guiding the needle into position. Needle deflection and 
deformation can occur when inserting needles into soft, non 
homogeneous tissues, which can affect the localized accuracy 
of insertion. 
Currently, the most commonly used clinical strategy to 
visualize the direction of the needle shaft in real time is 
ultrasound guidance. However, the needle tip can often be 
visualized better than the needle shaft because of the irregular 
surface of the machine-cut bevel, which scatters the ultra 
Sound (US) beam in all directions, reflecting the beam, in part, 
back to the transducer. However, visibility of the tip alone is 
not sufficient for the clinician to gauge the insertion angle of 
the needle. Visibility of the needle shaft is dependent on the 
angle of the needle relative to the transducer and is best 
visualized only when perpendicular and in the plane of the US 
transducer. Needle deflections away from the transducer of 
only a few degrees are usually enough to conceal the US 
signal from the needle. To overcome these issues, mechanical 
or optical needle guides are often used to keep the needle in 
the transducer plane. However, these guides restrict needle 
movement when fine adjustments are needed by medical 
operators; therefore, many clinicians prefer using a freehand 
technique during needle insertion and injection. 
US imaging of metal needles also produces an unexpected 
echographic pattern resembling the shape of a comet tail. The 
pattern is due to reverberations within the needle and is 
dependent on the acoustic impedance mismatch between the 
needle and its Surroundings. In fact, these artifacts are present 













can be helpful in determining the presence of foreign metal in 
vivo, the existence of the comet tail pattern prevents visibility 
of objects directly distal and adjacent to the needle (relative to 
the position of the transducer). This effect can detrimentally 
affect the ability to determine needle position relative to the 
background tissue. 
Likewise, when using current ultrasound technology to 
track needle insertions/interventions, tissue background has 
been determined through the ultrasound speckle shown on the 
imaging screen. However, the acoustic speckle between dif 
ferent tissue compositions does not always offerenough con 
trast in order to determine what tissue landmarks the needle 
tip has penetrated to. Though photoacoustic imaging can 
utilize optical absorption to differentiate tissue types, some 
tissues have very low absorption and therefore may have very 
low signals when imaged under photoacoustic imaging. The 
difference in acoustic scattering between healthy and dis 
eased tissue is not usually very high. Therefore, needle tra 
jectories can oftentimes miss the region of interest that the 
operator is interested in when basing decisions on ultrasound 
alone. Furthermore, when targeting needle interventions into 
Soft tissue, the real-time imaging modality should confirm the 
arrival of the needle into the region of interest. Without con 
firmation of needle arrival, false negatives can occur when 
conducting biopsies. 
Current technologies only allow for needle tracking with 
limited to no tissue characterization. In ultrasound, only land 
marks that contain strong differences in acoustic scattering 
can be differentiated. Similarly, in photoacoustic imaging 
alone, only tissue with strong optical absorption can be visu 
alized. For example, fat is not easily differentiated from 
muscle in ultrasound, nor does it have a high absorption for 
visualization in photoacoustics. 
In addition to temporary metal implants, permanent metal 
implants, such as coronary arterial stents, are also used clini 
cally within the human body. Coronary stents are currently 
the most widely used coronary intervention in the United 
States. While the procedure is more than 95% successful, 
stents have brought along several unique issues including 
restenosis, hyperplasia and stent drift. The ability to visualize 
stents both during the stenting procedure and during post 
Surgery follow-up is important in order to correctly assess the 
stent with respect to the plaques and vessel, and also identify 
its apposition within the vessel wall. 
Immediately following a stenting procedure, it is important 
to determine the relation of the stent struts to the vessel wall. 
Ideally, the stent is deployed in contact with the lumen wall; 
however, malapposition can occur resulting in the stent 
detaching itself from the wall. This detachment can cause 
turbulent eddies to form in the vessel which can lead to 
thrombosis in the area of the stent. It is important when 
monitoring the stent to determine how much restenosis has 
formed around the stent struts. The distance that the stent 
struts are embedded into the vessel wall must be determined 
to assess stent viability. 
Currently, the most common method for assessing stent 
position is X-ray coronary angiography/fluoroscopy. How 
ever, this procedure is problematic due to its use of ionizing 
radiation and possible complications in using iodinated con 
trast agents. Furthermore, X-ray fluoroscopy can only depicta 
two-dimensional projection which can lead to an underesti 
mation of lumen diameter and the stent apposition within the 
lumen. 
Magnetic resonance imaging has been used to image stents 
due to its avoidance of radiation exposure and iodine contrast 
agents; however, the metallic composition of stents can cause 
susceptibility artifacts which can obscure the stent lumen and 
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make it very difficult to visualize the relation between the 
stent and the vessel wall. Long scan times and low resolution 
also remain a major limitation. Multi-slice computed tomo 
graphic angiography (MSCTA) has been shown to image 
much faster than MRI; however, its low resolution and arti 
facts in metallic stents make assessing the Surrounding vessel 
difficult. 
Both intravascular ultrasound (IVUS) and optical coher 
ence tomography (OCT) have reached widespread usage in 
catheterization labs. IVUS can detect signal reflections from 
the stent struts, but has insufficient contrast to determine the 
Struts position against the vessel wall. Ultrasound contrast of 
stents is affected by the background tissue environment, 
which is also acoustically scattering. In addition, extraneous 
beams of ultrasound generated by the ultrasound transmit 
pulse and then scattered by the metallic stents will obscure the 
edges of the stent borders. These blurred edges are image 
artifacts that can reduce the spatial registration of the imaged 
stent. OCT directly competes with these disadvantages with a 
resolution of 10-20 um but has severe depth limitations, 
allowing only a penetration depth of about 2 mm. The pres 
ence of blood flowing through the vessel limits this depth 
even further, requiring clinicians to flush the vessel during the 
imaging procedure. Furthermore, the tissue behind the stent 
strut becomes hidden due to scattering shadows in OCT, 
which prevents complete diagnosis of the stent's relation to 
the vessel lumen. 
SUMMARY 
The present disclosure generally relates to ultrasound and 
photoacoustic imaging. More particularly, the present disclo 
Sure relates to combined ultrasound and photoacoustic imag 
ing of objects comprising metal. 
In one embodiment, the present disclosure provides a 
method comprising generating a photoacoustic image of at 
least a portion of a sample comprising a metal object; gener 
ating an ultrasound image of at least the portion of the sample 
comprising the metal object; and determining the location or 
positioning of the metal object within the sample by using an 
overlay of the photoacoustic image and the ultrasound image. 
In another embodiment, the present disclosure provides a 
method comprising exposing at least a portion of a sample 
comprising a metal object to electromagnetic radiation so as 
to generate an acoustic response; detecting the acoustic 
response with an acoustic sensor; generating a photoacoustic 
image of at least the portion of the sample comprising the 
metal object based on the acoustic response detected by the 
acoustic sensor; exposing at least a portion of the sample 
comprising the metal object to an acoustic Sound wave so as 
to generate an echo; detecting the echo with the acoustic 
sensor; and generating an ultrasound image of at least the 
portion of the sample comprising the metal object based on 
the echo detected by the acoustic sensor. 
In yet another embodiment, the present disclosure provides 
a method comprising generating a photoacoustic image of at 
least a portion of a sample comprising a metal object; gener 
ating an ultrasound image of at least the portion of the sample 
comprising the metal object; and employing a filtering tech 
nique so as to at least partially remove or reduce an echo 
graphic pattern due to acoustic reverberation from the pho 
toacoustic or ultrasound image. 
The features and advantages of the present invention will 













changes may be made by those skilled in the art, Such changes 
are within the spirit of the invention. 
DRAWINGS 
Some specific example embodiments of the disclosure may 
be understood by referring, in part, to the following descrip 
tion and the accompanying drawings. 
FIGS. 1A and 1B are photographs of the first vessel mim 
icking phantom with a stent embedded in the lumen wall. A 
5.0 mm inner diameter stainless steel stent was molded 1 mm 
deep within the vessel wall from the lumen. An 8 mm long 
region of the stent was left bare outside of the phantom vessel, 
which was constructed from 8% cross-linked polyvinyl alco 
hol (PVA). 
FIG. 2 is a cut-away diagram of the second vessel phantom 
consisting of three regions of varying distances between the 
stent and the vessel wall to model embedded (within the 
vessel wall), deployed (adjacent to the vessel wall), and mal 
apposed (separate from the vessel wall) stents. 
FIG. 3A is an image depicting an overall IVUS/IVPA 
imaging system, according to one embodiment. 
FIG. 3B is an ex-Vivo prototype photoacoustic imaging 
setup, according to one embodiment. The vessel was placed 
in a water tank and externally illuminated using an optical 
fiber. The ultrasound imaging catheter was placed inside the 
lumen and the vessel was rotated incrementally as IVUS/ 
IVPA A-lines were collected. 
FIG.3C is a diagram of an integrated IVUS/IVPA imaging 
catheter where the IVUS probe and fiber-optical light deliv 
ery system are combined for in-vivo intravascular imaging. 
FIG. 4A is an ultrasound (IVUS) cross-sectional image of 
the stent deployed within the vessel phantom. 
FIG. 4B is a photoacoustic (IVPA) cross-sectional image 
of the stent deployed within the vessel phantom. 
FIG.4C is an overlay of the two images shown in FIGS. 4A 
and 4B, which together show the position of the stent struts 
with respect to the thickness of the vessel wall. 
FIGS. 5A-5C are three-dimensional (3D) reconstructions 
of the vessel and stent. The 3D images were created by acquir 
ing a stack of cross-sectional images and combining them 
together. The ultrasound and photoacoustic signals can be 
displayed with different transparency in the reconstructed 
image to show the position and shape of the stent within the 
vessel. 
FIGS. 6A-6Care intravascular ultrasound and photoacous 
tic and combined IVUS/IVPA images from the three different 
regions in the stented vessel. (A) Stent embedded within the 
vessel. (B) Stent adjacent to lumen wall. (C)Stent detached 
from lumen wall. 
FIGS. 7A-7D are 3D-reconstructions of the tri-sectional 
phantom. Individual cross sections can show the position of 
the stent within the vessel. (A) Ultrasound 3D reconstruction 
of the phantom showing the structure of the vessel. (B) Pho 
toacoustic reconstruction of the stent structure which can be 
used to assess the condition of the stent. (C) Photoacoustic 
image of the stent overlaid with the ultrasound image of the 
vessel can show the position of both. (D) Cut-away image of 
the reconstruction, allowing for accurate assessment of the 
stent within the vessel. 
FIG. 8 is IVUS/IVPA imaging of vessel-mimicking phan 
tom in transparent (i.e. non-scattering) and Scattering 
medium. Ultrasound images displayed at 55 dB. Photoacous 
tic images in water and Scattering medium displayed at 15 dB 
and 10 dB, respectively. 
FIG. 9 is an image depicting an experimental setup for 
imaging metal needles in a porcine tissue sample. An imaging 
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probe comprising a 7-MHZ linear array transducer and an 
18-fiber bundle was positioned on the top of the sample. The 
pork sample was placed in a water tank for the purposes of 
acoustic coupling. The sample was irradiated at a 1064-nm 
wavelength. Laser fluence was approximately 10 m.J/cm. 
FIG. 10 is a schematic view of the 30-gauge (30 G) and 
21-gauge (21 G) needles. The 30G needle was inserted into 
pork loin tissue perpendicular, and later reinserted at an angle 
of approximately 15 deg to the surface of the US transducer. 
The 21 G needles were inserted at various angles relative to 
the US transducer. 
FIG. 11 is an image depicting an experimental setup for 
imaging of metal needles positioned at different angles in 
water and gelatin phantom. Imaging was performed with a 
single element US transducer (7 MHz, f/4). The center fre 
quency of this transducer was similar to the imaging array 
used in FIG. 9. The imaging sample was irradiated with 
800-nm-wavelength light. Laser fluence was also approxi 
mately 10 ml/cm. 
FIGS. 12A-12D are images of a hypodermic needle 
inserted perpendicular to the US transducer. The needle was 
inserted horizontally through the pork loin Sample. The trans 
ducer is located toward the top of the images. FIG. 12A is an 
US image of the needle cross section in pork sample: FIG. 
12B is a PA image of needle cross section, where the needle 
is easily visible: FIG. 12C is an US image of the needle and 
tissue in the transducer imaging plane; and FIG. 12D is a PA 
image of the needle in the transducer imaging plane, where 
the metal needle is clearly visible. The dimensions of the pork 
loin are approximately 30x30x30 mm. US images are dis 
played at 40 dB, PA images at 20 dB. 
FIGS. 13A-13C are images of the hypodermic needle 
inserted angled approximately 15 deg with respect to hori 
Zontal. The needle is repositioned in the same tissue as in FIG. 
12. The transducer is oriented at the top of the images. FIG. 
13A is an US image of the tissue containing the needle cross 
section; the angled needle is not visible: FIG. 13B is a PA 
image of same cross section as FIG. 13A, the highly absorb 
ing needle appears very clearly: FIG. 13C combined US and 
PA image showing the exact location of the needle within the 
tissue. US images are displayed at 40dB. PA images at 20 dB. 
Since US and PA images are obtained at the same position, the 
two images are spatially coregistered. 
FIGS. 14A-14B are cross-sectional images of five 21 G 
needles in water. The needles are angled downward with 
respect to the horizontal plane. From left to right, needles are 
angled at 30, 20, 10, 5, and 0 deg, respectively. 
FIGS. 15A-15B are cross-sectional images of five 21 G 
needles inserted into a tissue-mimicking gelatin phantom 
containing optical scatterers. From left to right, needles are 
angled at 30, 20, 10, 5, and 0 deg downward with respect to 
the horizontal plane. 
FIGS. 16A-16C are PA images from FIG. 12D showing 
filtering technique to remove comet-tail artifacts; FIG.16A is 
an unfiltered PA image of the horizontal needle. The FFT of 
the signal shows one frequency peak at the center frequency 
of the transducer (7 MHz) and one at a lower frequency 
around 3 MHz, representing the signal from the comet tail; 
FIG. 16B is the result of bandpass filtering demonstrating 
incorrect choice of cut-off frequencies (3 to 10 MHz), low 
frequency components are still present, blurring out the arti 
facts; and FIG.16C is the correct bandpass filtering (4 to 10 
MHz), which eliminated the comet-tail artifact. Contrast-to 
noise ratios in FIGS. 16A, 16B and 16C were calculated to be 
39.3, 38.2, and 32.5 dB, respectively. 
FIGS. 17A and 17 B show individual A-lines of the rf 














comet-tail artifact. Though the images appear similar, the 
underlying signals are not. FIG.17A shows the PAA-line, the 
comet-tail artifact appears to be a continuous signal that 
diminishes over time, and FIG. 17B shows the US A-line at 
the same location. The comet-tail artifact in the US image 
appears as a discontinuous train of signal bursts that decrease 
in amplitude over time. 
FIGS. 18A-18C show (A) ultrasound (IVUS) and (B) pho 
toacoustic (IVPA) cross-sectional images of the stent 
deployed within an excised rabbit artery; (C) an overlay of the 
two images (A&E) together shows the position of the stent 
struts with respect to the thickness of the vessel wall. US and 
PA images are displayed at 55 dB and 25 dB, respectively. 
FIGS. 19 A-19B show (A) a correlation colormap based on 
multi-wavelength PA data obtained across multiple wave 
lengths and (B) correlation coefficients greater than 80% are 
then displayed overlaid on the US cross-sectional image. 
FIG.20 is a photograph of a metal wire inserted through the 
fat and muscle regions of porcine tissue. 
FIGS. 21A-21D show co-registered (A) ultrasound and (B) 
photoacoustic images of an 18-gauge needle inserted hori 
Zontally into porcine tissue; (c) ultrasound and (d) photoa 
coustic images of the same tissue with needle inserted at a 
steep angle. The needle is not visible in the ultrasound image 
but still visible in the photoacoustic image. Photoacoustic 
images are displayed at 40 dB. 
FIGS. 22A-22C show transverse images in ultrasound and 
photoacoustic of needle inserted into tissue; (A) Needle 
inserted horizontally 0°, (B) Needle at 5°, and (C) needle at 
10°. At 10, the needle is invisible in the ultrasound image. 
FIG. 23 is a chart depicting the relationship between signal 
to noise ratio and needle insertion angle. 
FIGS. 24A-24B show ultrasound and photoacoustic cross 
section images of a metal wire inserted horizontally in por 
cine tissue. 
FIG. 25 is a graph depicting the correlation between pho 
toacoustic intensity and tissue position on a tissue sample 
with varying tissue composition. 
FIG. 26 is a graph depicting the correlation between optical 
absorption and wavelength for several materials. 
FIGS. 27A-27C show a schematic representation of 3D 
phantom (A) and front (B) and side (C) view of a transducer 
rotation apparatus. Yellow triangle/rectangle represents gela 
tin background; green ellipsoid, seed; blue and gray rect 
angles, transducer and mount, respectively. Red-shaded 
regions denote laser irradiation, while black lines represent 
acoustic transmission, both of which are oversimplifications 
and included for illustration purposes only. Purple arrow indi 
cates transducer rotation axis. 
FIGS. 28A-28B depict (A) a picture of a prostate sample 
cast in gelatin and (B) schematic views of imaging orienta 
tions. In FIG. 28A, a green dot denotes approximate place 
ment of seed (long-axis perpendicular to table), a red line 
indicates example irradiation path, while US transducer is 
visible in upper-left portion of image (with aperture oriented 
perpendicular to table). White scale indicates varied distance 
of seed from front-most sample edge. In FIG. 28B, short 
(left) and long-axis (right) orientations are offered. The peach 
cube depicts the embedded prostate sample. 
FIG. 29 shows US and PA images of brachytherapy seeds 
at different rotation angles relative to transducer face. Seed 
schematics (blue background) denote orientation, while first 
image immediately right offers US B-mode depiction (gray 
scale) and second image offers PA imaging depiction (yel 
low-red colormap). PA and US images are displayed with a 
30-dB dynamic range, while all images (including schematic) 
are presented with same scale (i.e., seed is 0.8x4.5 mm) and 
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co-registered orientations/positions. Transducer face is 
located/aligned with top margin of schematic. 
FIGS. 30A-30B are graphs showing: (A) the normalized 
PA signal of seedembedded in gelatin (square) and embedded 
in excised bovine prostate (circle) and (B) the contrast spec- 5 
trum of seed embedded in the prostate sample. Proximal end 
of seed is embedded approximately 1 mm from prostate tissue 
Surface (in direction of laser Source). 
FIGS. 31A-31C show (A) US B-mode, (B) PA, and (C) 
combined PA/US images of a seed embedded in a bovine 10 
prostate sample in the long-axis orientation. PA image was 
acquired at 870 nm and is displayed with 35-dB dynamic 
range; B-mode image is displayed with 55-dB range. 
FIGS. 32A-32F depict normalized PA spectra and contrast 
of brachytherapy seed embedded in bovine prostate at three 15 
laser irradiation depths: 4 mm (AD), 10 mm (B.E), and 13 
mm (C.F). 
FIG.33 shows the average PA signal (obtained at 1064 nm 
(middle) and 800 nm (bottom)) produced by two control 
seeds (the outer two seeds) and three coated seeds (the inner 20 
three seeds). 
FIG.34 is a graph showing a quantitative comparison of the 
results from FIG.33, which presents average:SD (N=9) sig 
nal enhancement as a function of coating time. 
FIG. 35 depicts one embodiment of a combined IVUS, 25 
IVPA imaging system for tIVPA imaging. 
FIGS. 36A-36D show (A) IVUS and (B) combined IVUS/ 
IVPA (1210 nm wavelength) images of the atherosclerotic 
vessel. The images were acquired at 25° C. Yellow arrows in 
these images indicate the location of atherosclerotic plaques. 30 
FIG. 36C shows that an oil red O stain confirmed that the 
imaged aorta had lipid-rich plaques. The angular position of 
the histological slide was chosen based on the visual correla 
tion of the shape of the vessel wall in histology and the IVUS 
image. FIG. 36D is a graph showing the Comparison of the 35 
temperature dependent normalized amplitude of PA signal in 
plaque and the adventitia (error bars correspond to plus/mi 
nus one standard deviation). 
FIGS.37A-37B show (A) Thermal IVPA (tIVPA) and (B) 
spectroscopic IVPA (sIVPA) images of the same cross-sec- 40 
tion of the atherosclerotic artery. Lipid-rich atherosclerotic 
plaques have similar appearance in tIVPA and sIVPA images 
while periadventitial fat does not appear in the tIVPA image. 
FIG.38 is a graph showing the temperature dependence of 
the normalized amplitude of PA signal measured in a sample 45 
of rabbit's abdominal fat. 
The patent or application file contains at least one drawing 
executed in color. Copies of this patent or patent application 
publication with color drawing(s) will be provided by the 
Office upon request and payment of the necessary fee. 50 
While the present disclosure is susceptible to various modi 
fications and alternative forms, specific example embodi 
ments have been shown in the figures and are herein described 
in more detail. It should be understood, however, that the 
description of specific example embodiments is not intended 55 
to limit the invention to the particular forms disclosed, but on 
the contrary, this disclosure is to cover all modifications and 
equivalents as illustrated, in part, by the appended claims. 
DESCRIPTION 60 
The present disclosure generally relates to ultrasound and 
photoacoustic imaging. More particularly, the present disclo 
Sure relates to combined ultrasound and photoacoustic imag 
ing of objects comprising metal. 65 
In some embodiments, the methods of the present disclo 
Sure may provide the ability to visualize and/or track tempo 
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rarily or permanently implanted metal objects. As used 
herein, the term “metal object” refers to any object which 
comprises a metal or has an optical absorption coefficient 
similar to that of metal. Identification of a metal object in the 
body requires the visualization of landmarks in the body. 
Ultrasound alone cannot accomplish this due to artifacts, 
acoustic deflection off of metal Surfaces, a low contrast 
between the metal object and the background, and a low 
differentiation ability between healthy and diseased tissue. 
Accordingly, in certain embodiments, the methods of the 
present disclosure combine both US and PA imaging to offer 
the high contrast of metal objects in PA imaging with the 
co-registered imaging of anatomical positioning in US. Used 
in real time, this combination can offer a very powerful tool 
not only for identifying metal objects, but also for identifying 
their relative location to other structures in the body such as 
tumors and plaques. This ability to identify metal objects and 
their surroundings is advantageous in image-guided therapy. 
In addition, the present disclosure also provides methods 
utilizing the photoacoustic tracking of a metal object to detect 
and determine the tissue composition in which the metal 
object is located. Additional information about tissue com 
position can be provided to help target the metal object, Such 
as a metal needle, to the region of interest. The signal ampli 
tude from the metal object can signify the type of tissue 
environment Surrounding it, due to the photoacoustic 
enhancement effect of the Grüneisen coefficient (of the tissue 
environment) in the photoacoustic pressure equation. As will 
be further described below, different tissue environments 
have different Grüneisen coefficients, giving rise to higher or 
lower photoacoustic signals for absorbers (such as a metal 
object) inserted into these environments. 
Accordingly, in one embodiment, the methods of the 
present disclosure comprise generating a photoacoustic 
image of at least a portion of a sample comprising a metal 
object; generating an ultrasound image of at least the portion 
of the sample comprising the metal object; and determining 
the location or positioning of the metal object within the 
sample by using an overlay of the photoacoustic image and 
the ultrasound image. 
In one embodiment, generating a photoacoustic image of at 
least a portion of a sample comprising a metal object may 
comprise exposing at least a portion of the sample to electro 
magnetic radiation so as to generate an acoustic response, 
which may then be detected with an acoustic sensor. Based on 
the detected acoustic response, a corresponding photoacous 
tic image may be generated of at least the portion of the 
sample comprising the metal object. By way of brief expla 
nation, the photoacoustic effect results from irradiating at 
least a portion of the sample with electromagnetic radiation, 
Such as from a pulsed laser beam, to produce a thermoacous 
tic response. Through the process of optical absorption fol 
lowed by thermoelastic expansion, broadband acoustic waves 
are generated within the irradiated sample. Anacoustic sensor 
detects the acoustic waves from the irradiated sample, which 
is linearly related to the optical absorption coefficient Land 
the localized laser fluence. With respect to a metal object 
embedded within tissue, as metal experiences an optical 
absorption that is orders of magnitude greater than that expe 
rienced by the tissue, the acoustic response from the metal 
object is higher, relative to the background tissue, thereby 
providing an image that provides contrast between the metal 
and the tissue within which it is embedded. 
As previously mentioned, in Some embodiments, the meth 
ods of the present disclosure also comprise generating an 
ultrasound image of at least a portion of a sample comprising 
the metal object. In one embodiment, generating an ultra 
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Sound image of at least a portion of the sample comprising the 
metal object may comprise exposing at least a portion of the 
sample to an acoustic Sound wave so as to generate an echo, 
which may then be detected with an acoustic sensor. Based on 
the detected echo, a corresponding ultrasound image may be 
generated of at least the portion of the sample comprising the 
metal object. By way of brief explanation, ultrasound imag 
ing operates by transmitting an acoustic Sound wave, which is 
then reflected and/or scattered from a sample back to the 
acoustic sensor. Reconstructed images can provide structural 
and morphological information based on the acoustic scatter 
ers present in the sample. 
In some embodiments, the methods of the present disclo 
Sure further comprise determining the location or positioning 
of a metal object within the sample by using an overlay of a 
photoacoustic image and an ultrasound image. Accordingly, 
in these embodiments, the methods of the present disclosure 
may be particularly advantageous as the high contrast of the 
metal object obtained in the photoacoustic image may be 
combined with the anatomical positioning afforded by the 
ultrasound image so as to identify the location/positioning of 
a metal object and also its relative location to other structures. 
In some embodiments, the methods of the present disclo 
Sure may further comprise determining the composition of at 
least a portion of the sample within which a metal object is 
embedded. In one embodiment, the composition of the por 
tion of the sample proximate to the metal object may be 
determined, at least in part, by observing one or more changes 
in the amplitude of the generated acoustic response object. By 
way of explanation, the amplitude of the acoustic response 
can signify the type of tissue environment Surrounding the 
metal object, due to the photoacoustic enhancement effect of 
the Grüneisen coefficient (of the tissue environment) in the 
photoacoustic pressure equation shown below in Equation 1. 
Briefly, the photoacoustic effect may result from irradiating 
the sample in order to produce a thermal and acoustic 
response. Light energy that is absorbed in a local region of the 
sample may be converted into heat, and then may be con 
verted into pressure due to the thermoelastic expansion of the 
sample. An ultrasound transducer may be used to detect the 
produced initial pressure, which is linearly related to the 
optical absorption coefficient of the imaged inclusion, L, the 
localized laser fluence, d(Z), and the Grüneisen coefficient, 
T. of the Surrounding environment, as seen in Equation 1. 
Pool d(z)-T (1) 
The Grüneisen coefficient is a dimensionless parameter 
that describes the thermodynamic properties of the tissue 
environment (Equation 2). The parameter is comprised off, 
the thermoexpansion coefficient, c, speed of Sound through 
the surrounding medium, and C, the specific heat capacity. 
(2) 
For stainless steel, the absorption coefficient, L, is 2-3 
orders of magnitude greater than optically absorbing tissue 
constituents in-vivo for a given wavelength of light. Accord 
ingly, different tissue environments have different Grüneisen 
coefficients, giving rise to higher or lower photoacoustic sig 
nals for absorbers (such as a metal object) inserted into these 
environments. Furthermore, because (3, c, and C, are all 
temperature-dependent, tissue-specific parameters, the Gri 
neisen parameter T is also temperature-dependent and tissue 













tissue type at various temperatures is known, photoacoustic 
imaging can be used to remotely monitor the temperature 
change. Alternatively, tissue composition may also be iden 
tified based on temperature-dependent photoacoustic 
responses. 
As will be recognized by one of skill in the art with the 
benefit of this disclosure, any suitable source of electromag 
netic radiation may be used in the methods of the present 
disclosure. Examples of Suitable sources of electromagnetic 
radiation may include, but are not limited to, a light source 
Such as a laser, including a tunable pulsed laser or a fixed 
frequency pulsed laser. In some embodiments, a sample may 
be exposed to pulses of irradiation with a duration of about 1 
nanoseconds (“ns”) to about 1000 ns. When the sample to be 
imaged is simulated by a solid slab tissue, the radiation flu 
ence on the surface of the slab will be about 10 m.J/cm. For 
other configurations of the test sample, or for living human or 
non-human bodies the surface fluence will vary, but will 
always be in a range which is generally considered safe 
according to the ANSI laser operation standards. 
Furthermore, in accordance with the present disclosure, a 
wavelength of electromagnetic radiation may be chosen, inter 
alia, to match the type of tissue being image. For example, 
lipid has an optical absorption peak at approximately 1200 
nm. In one particular embodiment, the wavelength of elec 
tromagnetic radiation may be in the range of from about 500 
to 1200 nanometers. In other embodiments, the wavelength of 
electromagnetic radiation may be in the range of from about 
700 to 1100 nanometers. Similarly, in certain embodiments, 
more than one wavelength of electromagnetic radiation may 
be selected. For example, in one particular embodiment, the 
wavelength of electromagnetic radiation may be of two or 
more different wavelengths in the range of from about 500 to 
1200 nanometers. In other embodiments, the wavelength of 
electromagnetic radiation may be of two or more different 
wavelengths in the range of from about 700 to 1100 nanom 
eters. One of ordinary skill in the art with the benefit of this 
disclosure will be able to select an appropriate wavelength(s) 
based on the type of tissue sample being evaluated and/or 
based on other relevant factors. 
As previously mentioned, an acoustic response generated 
by an irradiated sample may be detected by an acoustic sen 
sor. As will be recognized by one of skill in the art with the 
benefit of this disclosure, any sensor capable of detecting an 
acoustic response may be used in the methods of the present 
disclosure. One example of a suitable acoustic sensor may 
include, but is not limited to, an ultrasonic sensor. Examples 
of such ultrasonic sensors may include, but are not limited to, 
transducers including piezoelectric films, such as polyvi 
nylidene fluoride, optical transducers, and optical interferom 
eters. 
In certain embodiments, an ultrasonic sensor may also 
serve as a source of pulsed acoustic sound waves utilized to 
obtain an ultrasound image of a sample. In Such embodi 
ments, a delay Switch may be coupled to a synchronous 
trigger of a laser Such that, after or before a photoacoustic 
image has been acquired, the acoustic detector will itself emit 
pulsed sound waves. The ultrasonic sensor may then detect 
echoes of these pulsed Sound waves so that the echoes may be 
utilized to obtain an ultrasound image of the sample. 
In some embodiments, a Suitable electromagnetic source 
and a suitable acoustic sensor may be combined into one 
system, which may also be capable of generating an image 
based, at least in part, on the detected acoustic responses. 
Systems suitable for use in the present disclosure may com 
prise not only a Suitable electromagnetic source, and a Suit 
able acoustic sensor, but may also comprise additional elec 
US 8,839,672 B2 
11 
tronic and mechanical components such as a pulser/receiver, 
a digitizer, a motion controller, a three-dimensional position 
ing stage, a stepper motor, a delay Switch, a microprocessor or 
data acquisition unit, and/or a display monitor. One of ordi 
nary skill in the art, with the benefit of this disclosure, will 
recognize additional electronic and mechanical components 
that may be suitable for use in the methods of the present 
disclosure. 
In one embodiment, the methods of the present disclosure 
may comprise using an intravascular ultrasound (IVUS)/in 
travascular photoacoustic (IVPA) imaging device, which may 
be a catheter-based imaging device. An IVUS/IVPA imaging 
device may be particularly useful when imaging coronary 
artery stents. Compared to noninvasive cardiovascular imag 
ing modalities such as MRI and CT combined IVUS/IVPA 
imaging can achieve higher spatial resolution depending on 
the transducer frequency used in the application. Further 
more, as compared to invasive but high resolution imaging 
modalities such as OCT, IVPA has a larger penetration depth 
of several millimeters relative to 1-2 mm imaging depth in 
OCT. In addition, by choosing the imaging wavelengths in the 
near-infrared (NIR) range where the optical absorption of 
oxygenated and deoxygenated blood is low, IVUS/IVPA 
imaging may be performed in the presence of luminal blood 
without the need to flush the vessel with saline. 
Samples suitable for use in the methods of the present 
disclosure may comprise any material that facilitates the 
propagation of electromagnetic radiation, and also facilitates 
acoustic wave propagation. In one particular embodiment, the 
sample may comprise biological tissue. Similarly, the meth 
ods of the present disclosure may be used in connection with 
any type of metal object. Examples of suitable metal objects 
may include, but are not limited to, a coronary artery stent, a 
needle, a brachytherapy seed, a Surgical staple, an orthopedic 
implant, a pacemaker wire, etc. 
Furthermore, in certain embodiments, the methods of the 
present disclosure may also be used to image a metal object 
that comprises a Substance that has a strong absorption peak 
at a specific wavelength. This would enable the metal absorp 
tion peaks to be tuned toward or away from wavelengths 
where a sample shows a strong photoacoustic signal, making 
the metal object easier to identify alongside other constitu 
ents, such as cancerous lesions. These Substances, which may 
be in the form of a coating on the metal object, may also be 
used concurrently with multi-wavelength photoacoustic 
imaging to differentiate a metal object from a sample as 
unique absorption peaks can be expected from the coated 
metal object. In certain embodiments, the coating may altera 
thermodynamic or optical property of the metal object so as to 
enhance, in relation to a non-coated metal object, the acoustic 
response generated when the metal object is exposed to elec 
tromagnetic radiation. Accordingly, in some embodiments, 
Such a coating may allow for increased detectability of the 
metal object or for detectability at deeper depths. 
Currently, echogenic needle polymer coatings exist that 
make the needle tip and shaft highly visible under ultrasound. 
Similar coatings with optically absorbing properties could 
also be coated onto the metal to make metal implants even 
more visible at other wavelengths in PA imaging. Various 
molecularly sensitive coatings could also be used so that the 
absorption properties of the coated metal would change 
depending on the tissue background in contact with the metal. 
These metals could also be used for specific tissue detection. 
Examples of other suitable coatings may include those com 
prising silica, gold, metal nanoparticles, and metal nanopar 













Finally, in certain embodiments, the methods of the present 
disclosure may also comprise employing a filtering technique 
So as to at least partially remove or reduce an unwanted 
echographic pattern, such as a comet tail, from a photoacous 
tic or ultrasound image. Examples of Suitable filtering tech 
niques may include, but are not limited to, a frequency-based 
filter selected by means of the frequency of the echographic 
pattern, a wavelet-based filter and a correlation-based filter 
based off of a multi-wavelength imaging technique. 
To facilitate a better understanding of the present inven 
tion, the following examples of certain aspects of some 
embodiments are given. In no way should the following 
examples be read to limit, or define, the entire scope of the 
invention. 
Example 1 
Photoacoustic Imaging of Stents 
Materials and Methods 
To test the feasibility of a combined intravascular ultra 
sound (IVUS) and intravascular photoacoustic (IVPA) based 
method to image stents, imaging studies were performed 
using 33 mm length, BXVelocity stents (Cordis) deployed in 
two vessel phantoms mimicking both acoustic and optical 
scattering properties of tissue. Both phantoms were about 25 
mm long with 10 mm outer diameter made of 8% polyvinyl 
alcohol (PVA). As prepared, PVA is an optically scattering 
material. For acoustic contrast, 0.1% by weight silica par 
ticles of 5 um size were added to the phantom material to act 
as ultrasound scatterers. 
The first phantom simulated an atherosclerotic vessel with 
a 3 mm inner diameter. The BXVelocity stent was embedded 
1 mm into the inner lumen of the vessel, completely encased 
within the lumen wall (FIG. 1). Eight millimeters of the stent 
protruded from one end of the phantom. 
The second vessel phantom consisted of three different 
regions where the stent, relative to the inner lumen, was 
embedded, deployed (adjacent to the vessel wall), and mal 
apposed (detached from the vessel wall) (FIG. 2). In this 
phantom, the stent was embedded approximately 1.0 mm 
within the vessel wall, directly adjacent to the wall, and 
approximately 1.0 mm malapposed from the vessel wall in 
the lumen in the different regions, respectively. The malap 
posed region was formed by separating the Stent from the 
PVA with a plastic mold. Although the stent was separated 
from the PVA vessel, the stent itself was covered with a thin 
film of PVA due to the molding process during the phantom 
preparation. 
The laboratory prototype of the IVUS/IVPA imaging setup 
is shown in FIG.3. Briefly, a tunable pulsed Nd:YAG pumped 
optical parametric oscillator laser system (Vibrant B, Opotek, 
Inc.) was used at 800 nm wavelength to optically illuminate 
the vessel phantom (FIG. 3A). The photoacoustic signal was 
detected by a 40 MHz IVUS imaging catheter (2.5 French, 
Atlantis SR Plus, Boston Scientific, Inc) which was placed 
within the lumen of the PVA phantom. The laser beam and the 
IVUS sensing element were first aligned prior to the experi 
ment to ensure detectability of the photoacoustic response 
from the phantom. In addition to collecting photoacoustic 
signals, ultrasound pulse-echo signals were also collected 
using the IVUS imaging catheter connected to an ultrasound 
pulser/receiver. The cross-sectional IVUS and IVPA images 
were obtained by rotating the vessel and acquiring 256 pho 
toacoustic/ultrasound A-lines. By longitudinally increment 
ing the phantom 248 um each frame, a series of 100 cross 
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sectional images was collected to reconstruct a three 
dimensional image of the phantom. 
In this ex-Vivo prototype imaging setup, external light 
delivery is unrealistic for in-vivo imaging (FIG. 3B). During 
an in-vivo IVPA imaging procedure using the integrated 
IVUS/IVPA imaging catheter, light would be fed into the 
vessel using a fiber optical delivery system (FIG. 3C) where 
optical absorption and scattering of blood will diminish the 
incident laser fluence on the vessel lumen and stent. There 
fore, to maximize light penetration at a given fluence and 
obtain Sufficient image contrast, light at 800 nm wavelength 
was used. At this range, blood is more optically scattering 
than it is optically absorbing. To mimic this scattering media, 
milk was substituted for the 30 cm scattering coefficient of 
oxygenated blood at 800 nm. The tip of the optical fiber was 
placed 5 mm away from the surface of the vessel to simulate 
the in-vivo IVUS/IVPA imaging where light would travel 
through blood (scattering environment) before reaching the 
vessel wall. Therefore, it was conjectured that photoacoustic 
images of the phantom Submersed into milk would be 
affected by light scattering similar to in-vivo imaging. 
Results 
The cross-sectional ultrasound image (40 dB display 
dynamic range) and photoacoustic image (15 dB range) of the 
first vessel phantom with the stent are shown in FIG. 4. The 
photoacoustic image shows very high contrast between the 
stent and the background. Indeed, photoacoustic signal from 
the stent struts is very strong due to the high optical absorp 
tion of metal compared to the vessel which has little to no 
photoacoustic response. By comparison, the ultrasound 
image visualizes the complete cross-section of the vessel 
including the structure and thickness variation of the vessel 
wall. Since the ultrasound and photoacoustic images are 
already spatially co-registered, combining the two images 
shows complementary information. The location of the stent 
(IVPA image) is given in relation to the vessel (IVUS image). 
Quantitatively, the radial distance from individual struts to the 
lumen wall, measured from the IVUS/IVPA image, varied 
between 0.7 to 1.2 mm. These measurements are in agree 
ment with the design of the phantom the phantom mold was 
milled to separate the lumen wall from the stent by approxi 
mately 1.0 mm. 
To visualize the entire vessel wall and the stent, a three 
dimensional (3D) image of the phantom was produced (FIG. 
5). To visualize the structure of the stent in the context of the 
structure of the phantom, the transparency of the ultrasound 
image was modified Such that the photoacoustic signal can be 
seen, showing the structure of the stent. 
The intravascular ultrasound, photoacoustic and combined 
IVUS/IVPA images of the second vessel phantom are shown 
in FIG. 6. By imaging at various locations along the length of 
the vessel, the distance between the stent and the lumen wall 
was assessed. In the region of the embedded stent (FIG. 6A). 
the distance of the stent struts to the lumenwall was measured 
to range from 0.7 to 1.0 mm. In the region where the stent was 
merely adjacent to the vessel wall (FIG. 6B), the image visu 
alized the correct position of the stent struts relative to the 
vessel wall. Finally, in the malapposed region (FIG. 6C) the 
stent struts were measured to be 0.8 to 1.1 mm away from the 
wall. The position of the stent struts varied due to preparation 
of the PVA phantom mold. However, the diameter of the stent 
was measured to be a constant 5.0 mm throughout the entire 
stent, in agreement with the specification set out by the manu 
facturer. Due to the molding process used in fabricating the 
malapposed section (FIG. 6C), a thin layer of PVA was 
formed on the surface of the stent. The presence of this PVA 














located. Nevertheless, IVPA imaging was unaffected. The 
images in FIG. 6C demonstrate that far more complex geom 
etries and positioning of stents within the vessel can be 
imaged using IVUS/IVPA imaging. 
Similar to the first phantom, a set of 80 cross-sectional 
images were combined to produce a 3D image of the vessel 
and stent (FIG. 7). By displaying the cut-away of the 3D 
reconstruction, the shape and position of the Stent within the 
vessel is easily assessed (FIG. 7D). Again, the photoacoustic 
image was able to visualize the stent (FIG. 7B) and to cor 
rectly measure the inner diameter of the stent to be exactly 5.0 
mm, the reported diameter for the stent. Furthermore, the 
stent could be visualized in the context of the vessel geometry 
(FIG.7C) to identify the regions of embedded, deployed, and 
malapposed stent (FIG. 7D). 
The experiments were also performed to identify the influ 
ence of luminal blood on the quality of photoacoustic imag 
ing. The comparison between the blood-simulating environ 
ment and the water environment showed virtually no 
difference in either the ultrasound or photoacoustic images 
(FIG. 8). As expected, photoacoustic signal intensity showed 
a small reduction in the peak signal intensity from the stent 
due to the optical scattering properties of the milk. Neverthe 
less, image quality was not significantly reduced—the stent 
within the vessel wall was clearly visualized in both images. 
Discussion 
The combined IVUS and IVPA imaging system was able to 
image several millimeters deep which is necessary for the 
intravascular imaging of coronary arteries. The high-fre 
quency 40 MHz IVUS catheter allowed for an axial resolution 
of several tens of micrometers in both IVUS and IVPA 
images. The resolution of IVUS/IVPA imaging is slightly 
worse compared to OCT imaging, but the larger imaging 
depth allowed for complete viewing of the 10 mm diameter 
vessel. Furthermore, the full structure of the phantom is vis 
ible, unobscured behind the stent struts, thus allowing the 
position of the stent within the vessel wall to be visible, 
whether or not the stent was hidden from view. 
Overall, the diameter of the stent was correctly measured 
throughout the stent according to the specification set out by 
the manufacturer. An in-vivo environment can cause 
implanted stents to be crushed or deformed which can lead to 
problems such as thrombosis or stent drift. Photoacoustic 
imaging allows for accurate assessment of not only the size of 
the stent but also the stent shape in relation to the implanted 
environment. 
The stent struts were always fully visible in the photoa 
coustic image, but at best only partially visible in the ultra 
Sound images. In these regions visible in ultrasound, the 
phantom background is hypoechoic and therefore the stent 
appears in the ultrasound image with Sufficient contrast 
against this background. In the phantoms used in this 
example, silica particles were added to provide acoustic scat 
tering. Regions that did not contain uniformly mixed silica 
particles appeared hypoechoic under ultrasound. However, 
under conditions where the local background regions were 
highly acoustically scattering, the stent was difficult to visu 
alize under ultrasound alone. Even in the malapposed region 
of the phantom (FIG. 6C) where traces of the stent struts can 
be seen, the presence of the PVA film reduced the ability to 
locate the struts using ultrasound alone. In the photoacoustic 
image, conversely, the contrast is determined by optical 
absorption. Since metal struts of the stent are strong light 
absorbers, the photoacoustic image revealed the precise loca 
tion of the metal struts. 
Since IVPA imaging is based on the same hardware as 
IVUS, it is understandable that photoacoustic imaging of 
US 8,839,672 B2 
15 
stents may be susceptible to similar artifacts seen in IVUS. 
These include artifacts due to off-centered positioning of the 
transducer within the lumen and acoustic reverberation arti 
facts within the metal stent implant. IVPA can also bring its 
own issues, including light delivery through tissue or through 
other optically attenuating materials. 
The optical attenuation of light in blood should not detri 
mentally affect imaging of stents in-vivo. In this example, the 
optic fiber was placed at a greater distance from the vessel 
surface than it would be from the inner boundary of the vessel 
wall in in-vivo imaging. In other words, in in-vivo experi 
ments the light would travel a smaller distance and be attenu 
ated less. Therefore, the resulting images in-vivo should be 
able to assess stent viability. Furthermore, laser pulse ener 
gies in this example, measured at the fiber output, were 
approximately 1.75 m.J. Due to the high optical absorption 
properties of metals, the energy used to obtain a photoacous 
tic response can be decreased. For IVPA imaging in real-time, 
necessary in the clinical environment, lower energies may be 
required to increase the laser pulse repetition rates. For these 
applications, a tunable OPO laser system may not be a suit 
able choice. However, pulsed Nd:YAG lasers operating at 
1064 nm could be considered as these lasers can have pulse 
repetition rates from 1 to 10 kHz. While the pulse energy of 
these lasers is only upwards of 100LJ, fluences similar to this 
example could be obtained by decreasing the fiber size or 
focusing the laser beam to a smaller diameter. It should be 
noted that smaller fiber sizes will undoubtedly be required in 
a clinical IVUS/IVPA system in order to meet lumen clear 
ance diameters for the combined imaging catheter containing 
the IVUS transducer and IVPA optical fiber. 
This example shows that IVUS/IVPA is a promising 
modality to image stents in vivo. 
Example 2 
Photoacoustic Imaging of Metal Needles in Tissue 
Experiments were performed using common commer 
cially available clinical metal needles inserted into tissue and 
tissue-mimicking phantoms. The presence of these clinical 
needles was detected using combined US and PA imaging. In 
each experiment, the acquired PA images outlined the pres 
ence of the metal implant, and the US image provided infor 
mation about the Surrounding structure. During postprocess 
ing, the comet tail artifacts were reduced using a filtering 
approach, thus enabling the previously distracted background 
in PA imaging to be better visualized. The combined US and 
PA imaging enabled accurate measurements of the needle's 
position within the tissue. The accuracy of these measure 
ments demonstrates the usefulness of PA imaging in visual 
izing metal needles and other metal implants in vivo. 
Materials and Methods 
To test the feasibility of US and PA to image metal needles 
in tissue, imaging studies were conducted using different 
sizes of needles. In the first experiment, a Cortex ultrasound 
imaging system (Winprobe Corporation, North Palm Beach, 
Fla.) was used for rf data acquisition (FIG.9). This US system 
was interfaced with a 7-MHz center frequency, 14-mm-wide, 
128-element linear array transducer to image the needles. An 
Nd:YAG pump laser output (Vibrant B, Opotek, Inc., Carls 
bad, Calif.) at 1064 nm was used to optically illuminate the 
tissue phantom. Laser fluence in all experiments was mea 
sured to be approximately 10 mlcm. Laser light was deliv 
ered throughan 18-fiber optical bundle fixed around the trans 
ducer, and the needle sample was placed in the imaging plane 













enabled both light and Sound delivery along the same plane. 
Each fiber in the bundle was 0.6 mm in diameter with a 
numerical aperture (NA) of 0.22. Fiberbundle efficiency was 
approximately 60%. In this example, a 30-gauge (30 G)x1.0- 
in. hypodermic syringe needle (FIG. 10), made of 305 bulk 
stainless steel (Becton Dickinson, Franklin Lakes, N.J.) was 
inserted horizontally into a fresh healthy porcine muscle 
specimen. The approximately 30x30x30 mm tissue sample 
was immersed in water for acoustic coupling between the US 
transducer and the tissue (FIG.9). US and PA rf signals were 
collected with the needle oriented orthogonal to the imaging 
plane, then the transducer was axially rotated 90 deg, and the 
imaging procedure repeated, capturing the length of the 
needle in the imaging plane. 
To investigate the angular dependence of the US and PA 
signal, a second experiment was performed using a 7.5-MHz, 
f74, single-element transducer, mechanically scanned across 
the axial dimension of a set of needles using both US and PA 
imaging (FIG. 11). The purpose of this experiment was to 
determine the needle angles at which the metal needle would 
be visible, both in US and PA imaging and to demonstrate the 
effectiveness of PA imaging for detecting needles which are 
more often than not inserted angled from the transducer. Five 
21 Gx 1.0 in needles made of 305 bulk stainless steel (Becton 
Dickinson, Franklin Lakes, N.J.) were positioned both in 
water and in gelatin phantoms at angles of 0, 5, 10, 20, and 30 
deg relative to the horizontal plane, i.e., the surface of the US 
transducer. The gelatin phantom was created using 6% gelatin 
by weight, and a small amount (less than 1%) of 40-um-size 
silica particles, which served as optical scatterers. PA imag 
ing was conducted at 800 nm and light was delivered using a 
single optical fiber. The fiber had a diameter of 1.5 mm and an 
NA of 0.39. 
Results 
In the first experiment, the metal needle, in porcine tissue, 
was inserted parallel to the transducer Surface and perpen 
dicular to the imaging plane. Cross-sectional US and PA 
images of the needle and tissue were produced (FIGS. 12A 
and 12B). The US image (FIG. 12A) shows a bright signal in 
the middle of the image where the needle is located. Sur 
rounding the needle's signal is the US speckle obtained from 
the porcine tissue. The PA image at the same position also 
showed a bright signal in the center corresponding to the 
needle cross section. After obtaining these images, the sample 
was rotated 90 deg relative to the transducer, aligning the 
needle shaft directly in the imaging plane of the transducer 
(FIGS. 12C and 12D). Similarly, the US image (FIG. 12C) 
displays a bright acoustic reflection from the needle, Sur 
rounded by acoustic speckle from the tissue background. The 
PA image of the needle shaft (FIG.12D) also produced a large 
signal from the needle, but very little signal from the back 
ground, similar to the PA image in (FIG. 12B). As the metal 
needle was placed parallel to the transducer Surface in these 
images, the needle was easily visible in the US and PA 
images. At this orientation (i.e., a perpendicular angle 
between the axis of the US beam and longitudinal axis of the 
needle), the needle produced a strong US signal due to the 
high specular reflectivity of the needle. US comet-tail arti 
facts were also created behind the needle since acoustic 
waves were reflected within the needle, creating additional 
signals that appeared to propagate beyond and around the 
needle. The artifacts introduced into the US image, subse 
quently reduced the ability to determine the precise location 
of the needle. However, the comet tail made it very easy for 
the needle's presence to be identified in the image. The PA 
signals here also confirmed the presence of the highly absorb 
ing metal needle. US and PA images (FIG. 13) were also 
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obtained with the needle inserted into the phantom at a slight 
downward angle. In these images, the cross section of the 
needle was once again located in the center of the images, 
similar to FIGS. 12A and 12B. However, the needle here was 
angled away from the transducer. The US image still showed 
the background speckle of the porcine tissue, but the needle in 
the center of the image could not be easily visualized (FIG. 
13A). A PA image was also obtained at the same position 
(FIG. 13B). Despite the angled needle being invisible in the 
US image, the PA image still showed a bright spot in the 
center of the image where the cross section of the needle was 
located. By combining FIGS. 13A and 13B, the coregistered 
US and PA images displayed the presence of the angled 
needle in the tissue background (FIG. 13C). 
In the US image, the angled needle reflected the acoustic 
pulses away from the transducer, thereby decreasing the sig 
nal intensity from the needle, resulting in decreased visibility 
in the resulting image. However, the PA signal was not sig 
nificantly affected by this angular dependence and the needle 
remained highly visible within the tissue background even 
when it was not perpendicular to the transducer. In general, 
the PA response from rounded objects occurs omnidirection 
ally, which enables the signal to be less affected by the needle 
angle compared to the US image. Comet-tail artifacts are, 
however, directionally dependent, which is why they are not 
visible in the image of an angled needle. Furthermore and 
more importantly, there is excellent contrast in the PA 
response between the needle and the background tissue. 
In the second experiment, cross-sectional US and PA 
images of the five angled 21 G needles were obtained (FIGS. 
14A-14B). From left to right, the needles were inserted into 
an acrylic holder at decreasing angles from 30 to 0 deg. The 
US image (FIG. 14A) shows the cross sections of the needle 
with decreasing visibility as the needle angle was increased. 
Similarly, the PA image (FIG. 14B) shows the needles at the 
same position but with less decrease in signal as needle angle 
was increased. The addition of the gelatin phantom back 
ground in FIGS. 15A-15B show both the US and PA images 
of the needles, similar to FIGS. 14A and 14B. The US image 
of the needles in the gelatin phantom shows overall decreased 
visibility of the needles in the presence of the background 
speckle (FIG. 15A). On the other hand, all the needles were 
fully visible in the PA image (FIG. 15B); the PA signal inten 
sity did not decline with needle orientation at the angles used 
in this experiment. Furthermore, the presence of optical scat 
terers helped to deliver light within the phantom. FIG. 15B 
shows increased PA signal due to better light delivery to the 
needles in the phantom. 
In both the water (FIG. 14) and the tissue-mimicking phan 
tom (FIG. 15) experiments, the maximum signal intensity 
came from the needles that were horizontal from the trans 
ducer surface. In water, all the needles were at least dimly 
visible in the US image, although the signal intensity and 
spatial resolution was severely limited at needles angled 
greater than 10 deg. The addition of acoustic scatterers in the 
phantom background made the needles less visible under US. 
Needles at angles greater than 10 deg were invisible against 
the background. The PA signals from the needles remained 
easily visible in the gelatin, except for a slight decrease in 
signal intensity due to light attenuation from the phantom. 
This did not adversely affect the imaging of the needles, as 
they were still very visible due to the high absorption coeffi 
cient of metal. 
Discussion and Conclusions 
US and PA images of needles are shown in FIGS. 12-15. In 
each set of images, the PA images showed very high contrast 













Indeed, the PA signal from the metal is very strong due to the 
high optical absorption of metal compared to the gelatin 
phantom, which has little to no PA response and therefore 
results in very high contrast. In tissue, high contrast between 
the metal structure and tissue constituents was also found. 
Optical absorption of other tissue constituents is generally 
known to be far lower than that from the metal in the near-IR 
spectrum range. By comparison, the US image visualized the 
tissue structure and morphological features. Since the US and 
PA images were already spatially coregistered, combining the 
two images showed complementary information. The loca 
tions of the metal implants (PA image) were given in relation 
to the background tissue (US image). 
Both experiments showed strong comet-tail artifacts when 
imaged with US and PA imaging. Fast Fourier transforms 
(FFTs) of the a-lines containing rf signals showed that the 
frequency content of the comet tail was slightly different than 
the center frequency of the transducer. Therefore, bandpass 
filtering was performed to reduce the artifacts from the PA 
image of the needle in FIG. 12. Prior to applying the signal 
filter, comet-tail artifacts could be seen emanating from the 
position of the needle in the PA image (FIG. 16A). When 
correct bandpass filtering was performed (4 to 10 MHz), the 
comet tail disappeared from the image (FIG.16C). However, 
specifying the incorrect frequency range (3 to 10 MHz) 
resulted in an undesired treatment of the image and did not 
correctly remove the image artifacts (FIG. 16B). 
Bandpass filtering was able to remove the image artifacts, 
albeit at a decrease in the contrast-to-noise ratio (CNR). With 
out filtering, the CNR of FIG. 16A was found to be 39.3 dB. 
FIG.16B was reported to contain a CNR of 38.2 dB, and FIG. 
16C had a CNR of 32.5 dB. 
Attempts to perform the same filtering technique to the US 
image were unsuccessful. Examination of the time domain 
signal revealed that the comet-tail artifact produced in the US 
image contained a discontinuous signal different from the PA 
image. While the resulting artifacts in the US and PA signals 
were visually similar, the PA comet-tail signal was continu 
ous, decreasing overtime, similar to an acoustic reverberation 
(FIG. 17A). On the other hand, the US comet tail was discon 
tinuous, having burst-like signals that decreased in amplitude 
over time (FIG. 17B). These burst-like signals in the US 
image are therefore not easily removed without using more 
advanced filtering methods. 
The combined US and PA imaging modality was able to 
image 1 to 2 cm into tissue, the depth necessary for the 
imaging of metal needles inserted into the body. The current 
practice of using US imaging for guidance is ineffective to 
image metal in all cases, especially where highly reflective 
surfaces redirect US echoes away from the transducer. In 
most cases, clinicians are only able to use the US shadows 
from the metal to infer the location of the needle. The experi 
mental results presented here demonstrate that PA imaging is 
Suitable for imaging metal. Combined with US imaging, the 
PA signal from the metal inclusions was visible in relation to 
its position to the Surrounding tissue/phantom structures, 
which were visible in the US signal. 
The use of 1064-nm-wavelength light is a huge advantage 
for clinical in Vivo settings due to the low cost and simplicity 
of the Nd:YAG laser, deep penetration of the light into tissue, 
and high PA contrast between metal objects and Surrounding 
tissue. By using a 1064-nm laser, users do not require an 
expensive, complex laser system to conduct imaging tests. At 
a 1064-nm wavelength, light offers deep penetration into 
tissue and therefore imaging will require less laser fluence for 
the PA signal, while still preserving SNR, CNR, and safety. 
The imaging studies conducted here used laser energies well 
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below the maximum permissible exposure level set by the 
ANSI standard. These laser energies coupled with an array 
based imaging transducer make it possible to image PA sig 
nals in real time. The setup in this example was limited to a 
repetition rate of 10 Hz, but inexpensive lasers operating at 30 
HZ or higher could be used for real-time imaging. The PA 
contrast in the tissue studies demonstrated that at 1064 nm, 
metal was more highly absorbing than the Surrounding tissue, 
therefore showing that 1064 nm is an effective wavelength 
choice for imaging metal in the body. 
Though the first PA imaging example was conducted at 
1064 nm, the second experiment was conducted at 800 nm, 
Suggesting that multiple wavelengths could be used for spec 
troscopic PA imaging, which could be utilized to further 
differentiate between metal and tissue. Since the PA effect is 
directly related to optical absorption, PA data from multiple 
wavelengths could be used to calculate absorption spectra in 
the resulting image. Tissue constituents, having a unique 
optical absorption spectrum from metal, could then be differ 
entiated from the metal, identifying the composition of tissue 
with respect to the location of metal implants. 
The previous example 1 showed that PA imaging of metal 
in the body is not limited to needles. A host of metal devices 
are used in the human body, either temporarily or perma 
nently, many of which must be identified or monitored. As 
discussed in Example 1, combined intravascular US (IVUS) 
and PA imaging (IVPA) has been shown to image arterial 
stents and their positioning within the arterial wall. The com 
bination of IVUS and IVPA was found to give complemen 
tary information as the US image gave structural/morphologi 
cal information of the arterial wall, while the IVPA image 
could hypothetically show the location of the stent, its posi 
tion within the wall, and also the location of arterial plaques. 
It has also been proposed that this combined US and PA 
imaging could be used to image brachytherapy seeds during 
and after implantation into the body. Brachytherapy seeds are 
implanted to locally treat prostate cancer. However, the seeds 
have been found to migrate throughout the body, which can 
cause problems as they lodge themselves in other areas of the 
body Such as the lungs. PA imaging could be used to detect the 
location of the seeds as they shift around in the prostate. The 
imaging could be performed tomographically, reconstructing 
multiple slices of US and PA data to create a 3-D image of a 
localized region. 
Example 3 
Photoacoustic Imaging of Stents 
Materials and Methods 
An experiment was conducted to test the imaging and 
detection of a stent ex-vivo. An excised aorta from a rabbit 
model of atherosclerosis was used. In particular, a New 
Zealand white rabbit was kept under a low 0.2% cholesterol 
diet for 12 months. Rabbits under these dietary situations can 
develop severe atherosclerotic lesions in the aorta. The rabbit 
was sacrificed and the aorta was excised. A 4.5 mm inner 
diameter BXVelocityTM stent (Cordis) was deployed into the 
excised aorta according to the manufacturer recommended 
pressure rating. The stent was inflated to a pressure of 
approximately 12-14 atm, which resulted in an inflated diam 
eter of approximately 4.64-4.76 mm. Combined US and PA 
imaging was performed with a custom designed integrated 
catheter inserted into the lumen of the excised artery in a 
water tank. Spectroscopic PA imaging was performed from 













Laser fluence was measured at each pulse and used to nor 
malize the PA signal in post-processing. 
Images were processed using custom Matlab code written 
to process and display the scan-converted IVUS/IVPA 
images. For quantitative analysis, the PA signal was taken 
from a small kernel corresponding to an area where one stent 
Strut located, and confirmed based on the B-mode image. 
Data within this kernel was averaged to obtain a signal value 
for the center pixel. Data values were recorded across all 
wavelengths to obtain a rough optical spectrum from 650 to 
900 nm. This spectrum was then correlated to all other pixels 
in the image, taking into account the PA data obtained across 
all the wavelengths. Correlation values for each pixel were 
then overlaid in an image over the original PA image. 
Results 
Images were acquired from the experiment using a com 
bined IVUS/IVPA catheter to image a stent deployed in an 
excised rabbit aorta (FIGS. 18A-18C). Similar to the phan 
tom studies presented in Example 1, the stent struts appeared 
with high contrast in the PA images (FIG. 18B). The com 
bined US and PA image (FIG. 18C) showed good co-regis 
tration regarding the presence and location of the stent struts 
for half of the cross-section. The stent struts in the image from 
the 6 o'clock to 11 o'clock position were less visible in the 
image, but the comet-tail artifacts from each stent strut could 
still be seen. 
Spectroscopic analysis was also able to identify the pres 
ence of the stent based on the unique multi-wavelength PA 
signal of the metal (FIGS. 19A-19B). The location of the stent 
Struts as seen in the PA images showed good correlation with 
the spectrum of the original selected kernel. Each pixel was 
displayed according to a color bar (FIG. 19A), with high 
correlation pixels displayed in red, and low correlation in 
blue. It was observed that the comet-tail artifacts that 
appeared distal to each stent strut did not correlate well with 
the original kernel. Finally, pixels that showed a correlation 
coefficient greater than 80% were overlaid on the US image 
(FIG. 19B). 
Discussion 
From the ex-vivo tissue images, the stent struts were highly 
visible in the PA images. Each strut from the 12 o'clock to 6 
o'clock position produced a strong PA signal, but also a 
trailing comet-tail artifact similar to those seen in needles 
(Ziskin, M. C. etal. J Ultrasound Med, (1982). Su, J. L., et al. 
J. Biomed Opt., (2010)). Spectroscopic PA imaging demon 
strated the ability to isolate the signal from the metal stent 
Strut from its associated comet-tail artifact. This procedure 
shows that the amplitude of the comet-tail artifact produced is 
not linearly proportional to the optical absorption of metal. 
Multi-wavelength PA imaging could possibly be used as a 
process to filter out the comet-tail artifact, therefore isolating 
only the PA signal from the stent strut. 
However, the absence of strong PA signals from the 6 
o'clock to 11 o'clock positions in FIG. 18B, highlight an 
instrumentation issue rather than a fundamental limitation. 
For the combined IVUS/IVPA catheter used here, the optical 
and acoustic beams were only overlapped at a certain imaging 
depth, due to the construction of the catheter. 
Example 4 
Determining the Composition of Tissue Surrounding 
a Metal Needle Using Photoacoustic Imaging 
Materials and Methods 
To test the hypothesis that ultrasound and photoacoustic 
imaging is well Suited for imaging needles, and also for 
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detecting the Surrounding tissue composition, a set of ex-vivo 
experiments was performed on healthy porcine tissue. In the 
first experiment, an 18-gauge needle (Becton Dickinson, 
Franklin Lakes, N.J.) was also inserted into healthy porcine 
tissue horizontal and angled relative to the imaging trans 
ducer, and then imaged with the VEVO 2100 dual ultrasound/ 
photoacoustic imaging system (VisualSonics Inc. Toronto, 
Canada) using a 21-MHZ center frequency, 256-element, 
array transducer. A standard 21-gauge needle (Becton Dick 
inson, Franklin Lakes, N.J.) was also inserted into healthy 
porcine tissue at angles 0°, 5° and 10° relative to horizontal, 
and imaged with a 7.5 MHz center frequency, 128-element 
array transducer (Winprobe Corporation, North Palm Beach, 
Fla.). Photoacoustic imaging was performed with a tunable 
Nd:YAG pulsed laser (Spectra-Physics, Mountain View, 
Calif.) operating at 800 nm. Light was delivered using a fiber 
bundle that focused the light at approximately 2 cm from the 
ultrasound transducer Surface. The transducer was placed on 
the surface of the porcine tissue. Ultrasound gel was used for 
acoustic coupling between the transducer and the tissue. 
Images were collected with the needle in both longitudinal 
and transverse orientations. The resulting ultrasound and 
photoacoustic images demonstrate the high visibility of the 
needles using the photoacoustic modality. 
To test whether the photoacoustic signal could differentiate 
the tissue environment, a second experiment was performed. 
Healthy porcine tissue with distinct fat and muscle regions 
along the surface of the tissue was used. A 316L stainless steel 
wire, to mimic a fine needle (approximately 0.4 mm in diam 
eter), was inserted Superficially along the Surface of the tissue 
so that the muscle and fat regions were intersected along the 
length of the wire. FIG. 20 is a photograph of the metal wire 
inserted through the fat and muscle regions of the porcine 
tissue. The wire was inserted superficially through the surface 
of the tissue in order to reduce the effect of light extinction 
passing through the tissue in photoacoustic imaging. 
At any given region, the wire was only 1-2 mm deep inside 
the tissue. The shallow depth of the wire was chosen so that 
light attenuation through the tissue would not significantly 
affect the laser fluence irradiating the stainless steel wire. The 
same 21-MHZ transducer was also used here. An imaging 
pullback was performed in order for a three-dimensional 
image to be reconstructed of the tissue and wire. Images were 
normalized by laser fluence in post-processing, and the pho 
toacoustic intensity of the wire was plotted in relation to 
position in the tissue. 
FIGS. 21A and 21B show the combined ultrasound and 
photoacoustic images show the wire inserted longitudinally 
into tissue. When the wire was oriented horizontally with 
respect to the transducer head, both ultrasound and photoa 
coustic imaging are well-suited for imaging due to the high 
specular reflectivity in ultrasound, and high optical absorp 
tion in metal for photoacoustic imaging. However, when the 
insertion angle of the wire is slightly angled with respect to 
the transducer head, the wire is rendered invisible in the 
ultrasound image, as shown in FIG. 21C. However, as shown 
in FIG. 21D, the photoacoustic image continues to expose the 
presence of the wire. 
Signal degradation due to an increasing insertion angle is 
shown in FIGS. 22A-22C. FIG. 22A depicts 0°, FIG. 22B 
depicts 5°, and FIG.22C depicts 10°. As can be seen in FIG. 
22C, at 10 the wire is invisible in the ultrasound image. As 
the insertion angle increases, the signal ratio between the wire 
and the background decreases in both ultrasound and photoa 
coustic. However, the signal drops much more dramatically in 
the ultrasound. The contrast between the wire and the back 













signal loss in photoacoustic imaging is not as troublesome. 
The signal amplitude is less affected by wire angle, and the 
lack of background signal in the photoacoustic image results 
in a higher signal-to-noise ratio when it comes to identifying 
the position of the wire, as demonstrated in FIG. 23. Lack of 
background signal would not always be applicable as tissue 
constituents do have optical absorption, though absorption of 
metal is typically several orders larger. 
As can be seen in FIG. 23, signal to background ratio as a 
function of wire insertion. In the photoacoustic image, wire to 
background signal always remains higher than the corre 
sponding ultrasound image. At 10° where the wire is invis 
ible, as shown in FIG.22C, the signal-to-background ratio is 
very low. 
The photoacoustic signal from the wire study suggests that 
photoacoustic signals are significantly dependent on the Sur 
rounding tissue environment. The ultrasound and photoa 
coustic images correlate nicely. Since the wire is oriented 
horizontally with respect to the ultrasound transducer, the 
wire appears in both the ultrasound and photoacoustic 
images, as depicted in FIG. 24. Despite showing some pho 
toacoustic image artifacts, the only signal in the image is from 
the metal wires itself, as shown in FIG.24B. When the ampli 
tude of the wires’ photoacoustic signal is compared to tissue 
position the change in amplitude correlates well with the 
presence offat or muscle in the tissue sample. As can be seen 
in FIG. 25, data plots show that the photoacoustic amplitude 
is higher for the wire located in the fat region than in the 
muscle region. From a qualitative point of view, the data 
Suggest a higher signal from the metal wire when inserted into 
fat than muscle. The amount of signal enhancement correlates 
well with the difference in Grüneisen coefficients between 
pork fat and pork muscle which Suggests an enhancement of 
approximately 400%. 
Photoacoustic imaging in FIGS. 21 and 22 showed very 
high contrast between the wire and the porcine tissue back 
ground. The high contrast found in these images was due to 
the high absorption coefficient of metal compared to the 
porcine tissue which has little to no photoacoustic response. 
By comparison, the corresponding ultrasound image was able 
to visualize the background morphology of the tissue. Co 
registering the two images allows complementary informa 
tion to be known. That is, the location of the metal is known 
in relation to the background tissue. 
Both the ultrasound and photoacoustic image modalities 
could detect needles that were oriented horizontal to the 
transducer surface. Specular acoustic reflections off of the 
metals surface restricted ultrasounds ability to detect 
needles that were angled more than 10-15° away from the 
transducer. This specular reflection phenomenon did not 
affect photoacoustic imaging as much, as photoacoustic sig 
nals are produced omni-directionally from the Surface of 
irradiation by the laser. In so doing, photoacoustic signals 
from the metal surface can be more easily detected than 
reflected ultrasound pulses. 
The effect of tissue environment on photoacoustic ampli 
tude was demonstrated by the change in signal amplitude due 
to the metal's location in different tissue environment. While 
the results match qualitatively with the enhancement due to 
the Grüneisen coefficients, the mechanism by which this 
enhancement occurs is not yet quite understood. It is hypoth 
esized that the effect is due to the interfacial thermal resis 
tance between the surface of the bulk metal and the surround 
ing environment. 
While energy fluence was accounted for in the experimen 
tal trials, it is possible that light scattering and absorption 
would play a role in increasing or decreasing the amount of 
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energy incident upon the metal to generate the photoacoustic 
effect. However, by inserting the metal wire at a very shallow 
superficial depth below the tissue surface, the optical extinc 
tion due to tissue was diminished. 
FIG. 26 compares the optical absorption (ua) of stainless 5 
steel constituents (Cr2O and Fe2O) to the optical absorption 
of tissue constituents. As can be seen in FIG. 26, metal 
absorption (cm) is up to 3-4 orders of magnitude higher 
than strongly absorbing tissue. The higher La Values result in 
a higher PA signal. The Grüneisen coefficient of the surround- 10 
ing environment can also directly affect the resultant photoa 
coustic signal amplitude. Various tissue have unique Gri 
neisen coefficients which may allow comparison of tissue 
composition through photoacoustic signal amplitude. (e.g., 
porcine fat is approximately 400% higher than porcine 15 
muscle.) 
The present example demonstrates the increased utility of 
using photoacoustic imaging for the tracking of needles infor 
a variety of needle interventions. Combined with ultrasound, 
the use of photoacoustic imaging can provide the location of 20 
needles in tissue, while also visualizing the structure or mor 
phology of the tissue in ultrasound. Furthermore, the present 
example shows that there is a possibility of differentiating 
Surrounding tissue composition through photoacoustic imag 
ing of needles, even in cases when the optical absorption of 25 
tissue may be relatively low and the tissue composition can 
not be determined through spectroscopic photoacoustic tech 
n1dues. 
Example 5 30 
Photoacoustic Imaging of Prostate Brachytherapy 
Seeds 
Currently, the standard of care for the guidance of brachy- 35 
therapy seed implantation is transrectal ultrasound (TRUS), 
which can gain imaging access to the prostate given the 
gland's adjacency to the rectal wall and its modest size, with 
a meantSD diameter (i.e., height or width dimension), 
according to a study by Hricak et al., of 4.3+1.0 cm for men 40 
(n=15) aged 52-67 years. Since visualization of the small 
seeds can be difficult, the ultrasound-derived position of the 
needles—and not the seeds themselves—is often relied upon 
to infer seed placement. Acoustic shadowing from microcal 
cifications, off-axis seed placement (i.e., where the ultra- 45 
Sound beam widens), and placement in specific regions of the 
prostate (e.g., in the periprostatic region, which can have a 
similar echogenicity to the seeds) can make visualization of 
seeds with TRUS difficult. Additionally, the acoustic signal 
generated by a seed is highly dependent on its orientation, 50 
with seeds oriented with their long axis perpendicular to the 
beam more apt to being detected. Given the difficulty in 
accurately visualizing seeds with TRUS, CT imaging is typi 
cally utilized for post-implant dosimetric evaluations. Seed 
placement that deviates from the dosimetric treatment plan 55 
can result in underdosed cancerous regions, requiring post 
operative dose corrections through external-beam radiation 
therapy 3. Needle deflections of only 5° from the insertion 
angle decrease the minimum target dose by 10%, thus 
increasing the tumor-cell survival rate by a factor of 200. 60 
Materials and Methods 
To test the feasibility of US and PA to image brachytherapy 
seeds, several imaging studies were conducted using non 
reactive, stainless steel, iodine-125 brachytherapy seeds 
(IsoAid LLC, Port Richey, Fla.). Combined US and PA imag- 65 
ing studies were performed using a Cortex ultrasound imag 
ing system (Winprobe Corp., North Palm Beach, Fla.) that 
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was interfaced with a 7-MHz center frequency, 14-mm-wide, 
128-element linear array transducer (L7, Acuson Corp., 
Mountain View, Calif.). An Nd:YAG pump laser (Quanta-Ray 
PRO-290-10, Newport Corp., Irvine, Calif.) with OPO laser 
output (premiScan/BB 650 OPO, Newport Corp., Irvine, 
Calif.) and a nominal pulse width of 5 ns was synchronized to 
the ultrasound acquisition system to optically illuminate the 
sample in which the seed was embedded. The imaging system 
was capable of acquiring co-registered PA and US images. 
In the first experiment (i.e., the “angular dependence 
experiment'), the angular dependence of the US and PA 
signals on seed orientation was investigated. A non-reactive 
brachytherapy seed was embedded in 8% gelatin at 45° rela 
tive to the horizontal (FIGS. 27A and 27C). In an effort to 
evaluate the seed independently from background influences, 
acoustic/optical scatterers were not added to the gelatin phan 
tom. A mechanical stage was configured to rotate the trans 
ducer from 45° to 135° (relative to the same horizontal refer 
ence) in 15° increments. This allowed the long axis of the seed 
to be imaged at angles from 0 to 90° relative to the transducer 
face. Both the gelatin phantom and the transducer face were 
immersed in deionized water to provide acoustic coupling. 
The seed was placed at the fulcrum of the transducer's rota 
tion to ensure that the seed remained in approximately the 
same location in the transducer's field of view through the 90° 
rotation. The laser was operated at 800 nm for PA imaging and 
was delivered to the sample using a single optical fiber, the 
fiber had a diameter of 1.5 mm, an NA of 0.39, and was 
positioned at an oblique angle to the US beam axis (FIGS. 
27A and 27B). During the experiment, the laser irradiation 
position was not altered the optical fiber and seed were held 
fixed while only the transducer was rotated in order to dem 
onstrate that signal changes were due only to the positioning 
of the transducer relative to the seed. 
In a second experiment (i.e., the "bare seed spectrum 
experiment'), the spectrum of a bare seeds PA signal was 
established. A non-reactive seed was embedded in a block of 
8% gelatin and centered in the imaging plane with US imag 
ing (using the aforementioned system/transducer). PA images 
of the seed were then obtained from 750 to 1090 nm in 20-mm 
increments, including 1064 nm. The extinction spectrum of 
the gelatin alone was analyzed using a UV-VIS-NIR spectro 
photometer (UV-3600, Shimadzu Corp., Kyoto, Japan) and 
found to not significantly influence multi-wavelength PA 
imaging within the spectrum utilized for testing. 
A third experiment (i.e., the “prostate tissue experiment) 
was performed to examine combined US and PA imaging of 
brachytherapy seeds in a more realistic environment. In this 
experiment, five seeds were embedded into five excised 
bovine prostate samples, which were imaged within 24 hours 
of each animals sacrifice, were never frozen, and were cut to 
be cubical in shape. The proximal tip of each seed was buried 
approximately 1 mm below the surface of the tissue at varied 
distances away from each sample's edge (see white scale in 
FIG. 28A). Each prostate sample was then cast in gelatin to 
prevent tissue discoloration or deterioration due to water 
immersion. The first of the five samples was oriented so that 
the seed's long axis was perpendicular to the US transducer 
face (“Short-axis Orientation' in FIG. 28B). This orientation 
was chosen to provide a minimum irradiation path through 
the prostate tissue of 1 mm, a depth that was too shallow to 
achieve in the long-axis orientation. For this comparison, 
multi-wavelength PA imaging, from 750 to 1090 nm, was 
performed. The other four samples were then oriented so that 
the seed's long axis was positioned parallel to the US trans 
ducer face (“Long-axis Orientation' in FIG. 28B). Using US 
visualization, the depth of each seed from the sample's edge 
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was determined. Four irradiation path lengths were investi 
gated 4, 10, 13, and 17 mm—while PA images were 
acquired from 750 to 1090 nm in 40-nm increments, includ 
ing 1064 nm. Note that PA and US beams were orthogonal to 
one another and were made to penetrate comparable depths 
into the tissue (i.e., when the irradiation path was increased, 
the US propagation path was increased accordingly). 
For the second and third experiments, laser irradiation was 
delivered using an air beam directed at the seed. In all experi 
mentation, laser fluences were measured for each imaging 
trial, and the mean (n=500 pulses) energy was used to nor 
malize the PA amplitude. Standard deviation of the laser 
fluence was also used to calculate standard error in the PA 
amplitude at each wavelength. 
For quantitative analysis, PA signal energies were calcu 
lated using a kernel Surrounding the maximum signal from 
the seed. The kernel was determined by choosing a region of 
interest (ROI) with pixel values above a certain threshold in 
the B-mode image, which corresponded to the location of the 
seed. This region could be visually verified as the location of 
the seed due to the presence of the comet-tail artifact, which 
is present in US imaging of metals, that was located distally 
from the aforementioned ROI. Data points within the kernel 
were averaged and normalized according to the mean laser 
fluence obtained during each trial. For contrast calculations, 
data kernels (0.6x0.4 mm) for the signal and background 
ROIs were chosen in order to obtain kernels containing only 
the respective signal and background measurements. The size 
of the kernel did not significantly affect contrast calculations 
as long as each kernel only contained these signal or back 
ground measurements. Several contrast values were obtained 
by translating the position of the signal kernel through the 
region of the seed (identified by the US image); a correspond 
ing background kernel was similarly translated through an 
adjacent tissue region located outside the region of the seed. 
These values were then averaged together to obtain a single 
reported contrast value in US imaging and at each imaging 
wavelength in PA imaging. Contrast was calculated accord 
ing to equation 3 below: 
(3) 
Contrast = 
where S and S, are the mean signals from a region within the 
seed and adjacent background, respectively. 
Results 
In the angular dependence experiment, combined PA and 
US images of the brachytherapy seed were acquired from 0° 
to 90°, in 15° increments. In both the PA and US images, the 
seed remained visible as the transducer was rotated. In the US 
images (grayscale images in FIG. 29), when the seed was 
oriented at 0° relative to the horizontal, the entire seed was 
visible. A large comet-tail artifact was also visible due to 
reverberation of the acoustic signal within the seed. As the 
transducer was rotated, the acoustic signal weakened from the 
midsection of the seed, while the distal and proximal tips of 
the seed remained apparent. Through the full rotation, the 
peak US signal decreased by 13%, with the majority of that 
decrease occurring between 0° and 30°. 
Similar results were observed in the PA images of the seed 
(yellow-red colormap images in FIG. 29), where the 0° ori 
entation offered the best visualization of the full seed. The 













15° from the transducer; however, the signal diminished dra 
matically after that, as seen in rotation angles of 30° and 
greater. Much like the US images, comet-tail artifacts are 
present in the PA images. Unlike the US imaging results, 
however, only the proximal tip of the seed was clearly appar 
ent through the full rotation of the transducer. Through the full 
rotation, the peak PA signal decreased by 46%, with the 
majority of that decrease occurring between 15° and 30°. 
In the bare seed spectrum experiment, a seed embedded in 
pure gelatin was imaged with multi-wavelength PA imaging 
in order to determine the PA spectrum of the seed alone 
(square in FIG.30A). The normalized PA signal was plotted 
with respect to wavelength. The calculated spectrum pre 
sented a monotonically decreasing PA signal with increased 
laser wavelength, with an approximately 80% reduction in PA 
signal from 750 to 1090 nm. 
The third experiment involved inserting non-reactive seeds 
into excised bovine prostate tissue. FIG. 30A (circle) offers 
the PA spectrum of the seed shallowly embedded (short-axis 
orientation) in prostate tissue. Although the normalized PA 
signal tends to decrease with wavelength much like the bare 
seed (square in FIG. 30A), local minima in signal are 
observed from 950 to 1010 nm, while a local maximum is 
observed at 1050 nm. FIG. 30B shows the contrast spectrum 
for this seed in the short-axis orientation, with a peak (aver 
age) PA contrast of 40.1 dB (at 810 nm) compared to an 
average US contrast of 14.3 dB. FIG.31 shows the combined 
PA and US images obtained in the long-axis orientation from 
the 4-mm imaging depth. In the US image (FIG.31A), back 
ground speckle is visible throughout the prostate tissue, with 
the proximal tissue-gelatin boundary clearly visible at 1.2-1.5 
cm axially and the sample's edge visible at the 4-mm lateral 
position. Although a hyperechoic region is visible at the seed 
location (i.e., 2.4 cm), the speckle signal from the Surround 
ing tissue reduces overall contrast. A PA image (FIG. 31B) 
obtained at the same position presents a strong acoustic signal 
from the seed location, but little acoustic signal is present in 
the Surrounding tissue, resulting in a significant improvement 
in contrast. By combining FIGS. 31A and 31B, the co-regis 
tered images (FIG. 31C) are able to more clearly display the 
presence of the brachytherapy seed within the tissue back 
ground. 
Lastly, the seed was successfully imaged with three differ 
ent irradiation path lengths, and the PA signal spectrum of 
each was calculated at nine wavelengths (FIG. 32A-32C). 
Note that the seed could not be visualized at 17 mm with the 
utilized fluences, which were similar to those used for imag 
ing at the three shallower depths. For the other three depths 
(i.e., 4, 10, and 13 mm), a local maximum of the normalized 
PA signal exists at 1064 nm, while a local minimum can be 
observed at 990 nm. PA amplitudes for the 10-mm (b) and 
13-mm (c) acquisitions decreased, on average, by 93% and 
94%, respectively, when compared to the average PA ampli 
tude of the 4-mm (a) acquisition. FIGS. 32D-32F present the 
contrast values across the acquired spectrum for the three 
imaging depths. Peak (average) PA contrasts were 50.6 dB (at 
870 nm), 30.3 dB (at 830 nm), and 28.2 dB (at 1064 nm), 
while average US contrasts were 22.7 dB, 24.7 dB, and 25.5 
dB for the 4-mm, 10-mm, and 13-mm acquisitions, respec 
tively. Surface fluences were measured (meaniSD) across the 
acquired spectrum to be 21.7+2.3, 23.6+3.1, and 22.5+5.1 
mJ/cm for the 4-mm, 10-mm, and 13-mm acquisitions, 
respectively; fluences tended to decrease with increased 
wavelength. Specifically, at a wavelength of 1064 nm, surface 
fluences were measured to be 19.7+0.9, 21.3+0.9, and 
20.1+0.8 mJ/cm for the aforementioned acquisition depths, 
respectively. 
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Discussion 
PA imaging of brachytherapy seeds embedded in prostate 
tissue yielded an improvement of at most 27.9 dB in contrast 
over conventional US imaging, while seeds were successfully 
visualized at depths of up to 13 mm. Much like US imaging, 
PA imaging results were dependent on seed orientation. 
In the angular dependence experiment, US imaging results 
were similar to those observed by Davis et al., with the 0° 
orientation affording the greatest and most uniform acoustic 
signal. (B.J. Davis, R. R. Kinnick, M. Fatemi, E. P. Lief, R. A. 
Robb, and J. F. Greenleaf, “Measurement of the ultrasound 
backscatter signal from three seed types as a function of 
incidence angle: Application to permanent prostate brachy 
therapy.” Int. J. Radiat. Oncol. 57, 1174-1182 (2003)). This 
orientation maximizes the seeds Surface area that is perpen 
dicular to and within the path of the acoustic wave transmis 
Sion, which maximizes backscattered energy. Because the 
seed becomes an acoustic source when excited by the PA 
effect, PA imaging yielded very similar rotation results. Due 
to the seeds capsular geometry, the directivity pattern of the 
acoustic energy emanating from the seed yields the greatest 
energy at points normal to the seeds cylindrical midsection. 
If evenly irradiated, acoustic energy will radiate outward 
from the seed body. This explains why only the proximal tip 
of the seed is well visualized in PA imaging as the distal tip, 
which is rotated away from the transducer face, will tend to 
transmit energy in the opposing direction. 
In the bare seed spectrum experiment, the PA signal spec 
trum of a bare seed was found to monotonically decrease with 
increasing laser wavelength. The general trend of decreased 
absorption with increased wavelength observed in the spec 
trum for chromium-oxide (Solid turquoise line) is consistent 
with the similar decrease in PA signal—which is proportional 
to optical absorption—observed in this example. When the 
seed was shallowly embedded in prostate tissue, however, the 
generated PA signal spectrum has local minima from 950 to 
1010 nm. This phenomenon is likely related to the “environ 
mental' effect of the Surrounding tissue (optical) properties 
on the seeds PA signal. Though the PA signal amplitude is 
directly related to the optical absorption coefficient of the 
metallic seed, local fluence is also dependent on the optical 
absorption and scattering coefficients of the Surrounding tis 
Sue, resulting in a nonlinear dependence of the PA signal on 
tissue properties. 
In the depth dependence results, contrast plots (FIGS. 32D 
32F) were found to have local maxima at 1064 nm, with the 
deepest acquisition (13 mm) having its absolute maximum at 
this wavelength as well. Such a result is counter to what the 
results in the bare seed spectrum experiment might Suggest 
should occur (i.e., given that the PA signal was greatest at 750 
nm for the bare seed). In studies of human prostate, Scattering 
has been identified as the dominant loss mechanism and has 
been found to decrease with increasing irradiation wave 
length; this is typical for most soft tissues. Though the optical 
absorption of metal also decreases with increasing wave 
length, the reduction of this absorption with increased wave 
length is likely more modest than the decrease in local fluence 
that results from scattering at lower wavelengths. Given that 
the obtained PA signal is directly proportional to both optical 
absorption and local fluence, increasing imaging depth— 
which reduces local fluence but has no effect on optical 
absorption—appears to favor higher wavelengths. A local 
minimum in all of the spectra is observed at 990 nm, a phe 
nomenon which is consistent with the more finely sampled 
spectrum (circle in FIG. 30A) acquired for the shallowly 













between the absorption/scattering properties of the prostate 
tissue and the decreasing absorption of metal with increasing 
wavelength. 
Contrast values obtained from the PA images of the seed in 
prostate tissue (FIGS.30B and 32D-32F) highlight the impor 
tance of local fluence and seed orientation on seed visualiza 
tion. Firstly, a significant decrease in contrast was observed 
from the 4-mm imaging depth (50.6 dB) to the 10-mm and 
13-mm imaging depths (30.3 dB and 28.2 dB, respectively). 
This decrease is likely due to the drastic reduction in local 
fluence that results from increased scattering occurring 
through deeper interrogation regions; this notion is Supported 
by over 90% reductions in PA signals for these deeper inter 
rogations despite Surface fluences that were comparable to 
those used for the shallower, 4-mm interrogation. Addition 
ally, contrast appears to be affected by seed orientation. For 
the shallowly embedded seed that was imaged in the short 
axis orientation (FIG. 30B), a 10.5-dB reduction in peak 
contrast was observed between it and the 4-mm, long-axis 
orientation (FIG. 32D). This reduction is due in large part to 
the nearly 50% reduction in PA signal experienced with the 
rotation of the brachytherapy seed. Such a signal reduction— 
which also occurs but to a lesser extent for US imaging— 
would have resulted in US imaging slightly outperforming 
PA imaging (i.e., with theoretical contrasts of 24.3 dB and 
22.9 dB, respectively) for the 13-mm acquisition had the seed 
been imaged in the short-axis orientation. For the 4-mm 
acquisition, theoretical contrast calculations Suggest that PA 
imaging would have still outperformed US imaging had the 
seed been imaged in the short-axis orientation, with a slightly 
reduced contrast improvement (i.e., PA imaging over US 
imaging) of 24.4 dB (compared to a 27.9-dB improvement) 
being realized in this case. A study by Corbett et al. found, 
however, that the majority of seeds are placed approximately 
parallel (i.e., t16') to the transducer face during a clinical 
procedure. (J. F. Corbett, J. J. Jezioranski, J. Crook, T. Tran, 
and I.W. T.Yeung, “The effect of seed orientation deviations 
on the quality of 125 i prostate implants.” Phys. Med. Biol. 46, 
2785 (2001)). Thus, although the case of short-axis imaging is 
an important one to consider, seeds tend to be oriented for 
optimal PA imaging. Ultimately, to obtain an appreciable 
contrast gain in any orientation and fully realize PA imagings 
potential in this application, adequate local fluence at the seed 
location must be achieved. 
As previously noted, it was not possible to image a brachy 
therapy seed at a depth of 17 mm in the prostate tissue sample 
due to insufficient local fluence. In an effort to increase local 
fluence in a clinical setting, a fiber optic-based light delivery 
system could be introduced through a patient’s urethra. This 
would provide an additional irradiation source from within 
the tissue. With the urethra running through the prostate, 
maximum irradiation path lengths would be on the order of 
the prostate's radius (i.e., half the width or height dimension), 
which was found to have a mean of 21 mm in a study of men 
aged 52-67 years. (H. Hricak, R. Jeffrey, G. Dooms, and E. 
Tanagho. "Evaluation of prostate size: A comparison of ultra 
Sound and magnetic resonance imaging. Urol. Radiol. 9, 1-8 
(1988)). Consequently, as clinical application of this technol 
ogy requires imaging beyond the 13 mm demonstrated 
herein, the use of higher energies and reduced tissue scatter 
ing at 1064 nm could be critical in an effort to achieve clinical 
utilization. In clinical settings, at 1064 nm the American 
National Standards Institute (ANSI) allows for maximum 
safe laser fluences of 100 m.J/cm compared to 20 m.J/cm at 
<700 nm when imaging through skin. (American National 
Standards Institute, ANSI Z136.1-2007 American national 
standard for safe use of lasers (2007)). Although there is not 
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currently a specific fluence regulation for irradiation through 
either the rectal or urethral wall, the aforementioned ANSI 
limit for skin is likely a conservative estimate for what would 
be allowed for this application given the relatively high 
30 
mL isopropyl alcohol (IPA), and 3.6 mL of 3 vol% TEOS in 
IPA. To initiate the reaction, the pH was increased to 11 by 
adding 3.6 mL of an ammonium hydroxide solution (0.108 
mL of 30% ammonium hydroxide in 3.492 mL of IPA). The 
absorption of skin. Based on this limit, a five-fold increase in 5 reaction was kept at room temperature while stirring at 400 
surface fluence would be allowed in this example. Addition 
ally, it might also be possible to increase local fluence by 
increasing the laser's pulse width. From a practical stand 
point, the primary wavelength of an Nd:YAG laser is 1064 
nm, making systems capable of imaging at this wavelength 
readily available and relatively inexpensive. 
The rotation results from the first experiment demonstrate 
that PA imaging typically does not improve visualization of 
the full seed. When the seed is not approximately parallel to 
the transducer face, only the distal tip of the seed can be 
visualized with PA imaging, while both tips can be visualized 
with US imaging. The true improvement offered by PA imag 
ing is in detecting and locating the seed, as evidenced by as 
much as a 27.9-dB increase in contrast. In a study by Corbett 
et al., it was found that when multiple seeds are implanted, the 
placement of each seed is important in achieving the intended 
radiation dose distribution while the orientation is not. (J. F. 
Corbett, J.J. Jezioranski, J. Crook, T. Tran, and I.W. T.Yeung, 
“The effect of seed orientation deviations on the quality of 
125 i prostate implants.” Phys. Med. Biol. 46,2785 (2001)). 
Thus, PA imaging's enhanced capability of visualizing the 
location of seeds could improve a clinician’s ability to imple 
ment a specific treatment plan. 
Conclusion 
PA imaging promises improved contrast of brachytherapy 
seeds in tissue, yielding improvements ranging from 2.7 to 
27.9 dB in contrast over US imaging alone for seeds in the 
long-axis orientation and for imaging depths ranging from 4 
to 13 mm. Even more drastic than in US imaging, there is an 
angular dependence of a seeds PA signal, with the orientation 
having the greatest Surface area normal to the acoustic beam 
direction resulting in the greatest PA signal. To achieve sig 
nificant contrast improvements in a clinical application, 
which would call for imaging depths around 20 mm if a dual 
transurethral-transrectal irradiation source were imple 
mented, greater laser energies at increased wavelengths (e.g., 
1064 nm) may need to be utilized to obtain adequate local 
fluences. Accordingly, combined PA/US imaging shows 
strong promise in accurately visualizing the seed and Sur 
rounding tissue anatomy during brachytherapy seed place 
ment procedures. 
Example 6 
Silica-Coating-Induced Photoacoustic Imaging 
Signal Enhancement 
Titanium brachytherapy seeds were coated with silica to 
enhance the acoustic signal they produced during PA imag 
ing. Coated and non-coated (control) seeds were embedded in 
a transparent gelatin phantom and imaged with a modified 
(i.e., with PA imaging capability) Vevo 2100 imager to quan 
tify the PA signal enhancement resulting from silica coating. 
A 2- to 3-fold signal enhancement was observed between 
coated and non-coated seeds. 
Materials and Methods 
Titanium brachytherapy seeds (IsoAid LLC, Port Richey, 
Fla.) were coated in silica using the classic Sol-gel reaction 
mediated by the tetraethyl orthosilicate (TEOS) precursor 
(note that silica is the conventional name for the coating, but 
the more precise chemical name is siloxane). Specifically, Ti 












rpm for up to 20 hours. Seeds were removed and triple washed 
with water at various time points during the reaction to obtain 
varying layers of silica thickness on the Ti Surface. 
PA imaging studies were performed using a Vevo 2100 
ultrasound system (VisualSonics Inc., Toronto, Canada) that 
was interfaced with a 21-MHz center frequency linear array. 
AnNd:YAG pump laser (Quanta-Ray PRO-290-10, Newport 
Corp.) with a nominal pulse width of 5 ns was synchronized 
to the ultrasound acquisition system to optically illuminate 
the embedded seeds. Ten seeds—seven silica-coated seeds 
and three non-coated seeds—were arranged into two rows of 
fives seeds and embedded in 6% gelatin to facilitate PA imag 
ing analysis; a schematic of one of the seed rows is provided 
in the top panel of FIG. 33. The gelatin phantom with ten 
embedded seeds was then placed in a tank filled with deion 
ized water to allow for acoustic coupling during imaging. 
Three-dimensional PA imaging acquisitions were then 
obtained with the aforementioned imaging system. Imaging 
was performed at 800, 900, and 1064 nm with average pulse 
energies of 1.7, 0.9, and 0.3 m.J., respectively. The imaging 
transducer was translated laterally to nine distinct lateral 
locations (with both rows of seeds visible in the transducers 
field of view for each location) to allow for averaging of 
independent acquisitions (i.e., N=9 for each seed and wave 
length). 
Three-dimensional imaging datasets were segmented to 
provide the mean PA signal for each seed; the mean signal 
was calculated from a cubic volume that was centered about 
each seed and that had dimensions approximately equal to the 
major/minor axes of the capsular seeds. Mean signals for each 
seed were then divided by the mean signal from a control seed 
(i.e., non-coated) contained in that seeds row to calculate 
signal enhancement. 
Results and Discussion 
The bottom two images of FIG. 33 show the average PA 
signal produced by two control seeds (the outer two seeds) 
and three coated seeds (the inner three seeds). The PA images 
obtained at 1064 nm (middle) and 800 nm (bottom) qualita 
tively show an increase in the PA signal generation from the 
coated seeds when compared to the non-coated seeds. A 
quantitative comparison of these results is offered in FIG. 34. 
which presents averaget-SD (N=9) signal enhancement as a 
function of coating time. An approximately 2- to 3-fold 
enhancement is observed with the coated seeds. This 
enhancement increases with coating time until a maximum is 
reached (at 2.5 hours), at which time the enhancement 
decreases slightly. It is presumed that silica coating thickness 
is related to silica coating times. The mechanism for this 
silica-coating-mediated PA signal enhancement is thought to 
be thermodynamic in nature. 
Example 7 
Thermal Intravascular Photoacoustic (tIVPA) 
Imaging 
Materials and Methods 
Animal Model 
A Watanabe heritable hyperlipidemic (WHHL) rabbit was 
used as the animal model for atherosclerosis. WHHL rabbits 
have high LDL levels in circulating blood due to their genetic 
deficiency of LDL receptors. This type of rabbit can sponta 
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neously develop atherosclerosis in the aorta and coronary 
arteries. Lipid metabolism and atherosclerotic plaques of 
WHHL rabbit resemble that of human. Within 12 to 18 
months of age, severe plaques build up in the arteries of 
WHHL rabbits. 
In this example, the abdominal aorta procured from a one 
year old WHHL rabbit was used for tVPA imaging. Prior to 
imaging, WHHL rabbit was sacrificed and the segment of the 
aorta was removed and preserved in Saline damped gauze at 
4°C. Imaging experiments were performed within 24 hours 
after sacrificing the rabbit. 
Imaging System 
To image an excised vessel, a bench top, combined intra 
vascular IVUS/IVPA imaging system was used (FIG. 35). 
The ex vivo aorta sample was immersed inside a water cuvette 
filled with saline. A 40 MHz single element IVUS imaging 
catheter (Boston Scientific, Inc.) was placed inside the vessel 
lumen. The transducer located at the tip of the imaging cath 
eter was aligned with the optical fiber. The aorta sample was 
rotated by a stepper motor (Zaber, Inc.) for cross-sectional 
scanning. Each cross-sectional scanning consisted of 256 
A-lines. The laser source for IVPA imaging was provided by 
a tunable optical parametric oscillator (OPO) laser system 
(Spectra-Physics, Inc.) capable of generating laser pulses of 
approximately 3-5 ns duration at 10 HZ repetition rate. The 
energy of each laser pulse was recorded for off-line compen 
sation of the pulse-to-pulse laser energy variation. Once a 
laser pulse was generated, an analog to digital convertor card 
(CompuScope 14200, GaGe. Inc.) was triggered sample the 
radio frequency signal at a 200 MHZ sampling rate. After a 
user defined delay, a pulser/receiver (5073PR, Olympus, Inc.) 
was triggered for conventional intravascular ultrasound imag 
ing. The system was capable of acquiring co-registered IVPA 
and IVUS images of the aorta sample in cross-sectional view. 
Experimental Protocol 
The abdominal aorta sample was imaged ex vivo within 24 
hours after sacrificing the WHHL rabbit. During the imaging 
experiment, the aorta sample was placed inside the water 
cuvette with one end attached to a fixture connected to the 
stepper motor (FIG.35). The temperature of the aorta sample 
was changed by adding warm saline, and then cooled down 
with ice. In order to confirm that the temperature-dependent 
PA responses were consistent and reversible, the increase and 
decrease in temperature was repeated three times. Tissue 
temperature was monitored by a digital thermometer placed 
inside the water cuvette. 
Image Processing 
IVPA images acquired at two different temperatures were 
spatially averaged with a kernel size of 266 um (axial) by 15.5 
degree (azimuthal). The kernel size was around five times 
larger than the axial resolution and two times larger than the 
azimuthal resolution of IVPA imaging. The relatively large 
size of the kernel was selected to minimize the effect of the 
unwanted tissue motion caused by several factors including 
irregular mechanical rotation of the sample as well as addition 
of ice or warm saline to the water cuvette. Then, the finite 
difference of the PA amplitude between the two IVPA images 
was calculated as: 
S2 s (4) 
where S, ? is the PA signal amplitude at pixel attemperature 














difference map was then color-coded to form the t|VPA 
image, and displayed over the co-registered IVUS image to 
show the relative location and magnitude of the tVPA signal 
in context of vessel morphology. 
Results 
Rabbit aorta was imaged first at room temperature (25°C.) 
using combined IVUS/IVPA imaging system. IVPA imaging 
was performed at 1210 nm wavelength because lipid has a 
high optical absorption coefficient at this wavelength. Cross 
sectional IVUS image of the vessel showed two hypo-echoic 
regions that corresponded to the location of plaques (yellow 
arrows in FIG.36A). The combined IVUS/IVPA image of the 
same cross-section is presented in FIG. 36B. Strong PA sig 
nals present at the plaque region indicated that these plaques 
were rich in lipid. Strong PA signals were also observed at the 
periadventitial regions of the aorta. These signals may have 
originated from the periadventitial fat due to high optical 
absorption, high Surface optical fluence, and Subsurface opti 
cal fluence due to the refractive index mismatch between 
saline and arterial tissue. Oil red Ostain for lipid, performed 
on the tissue section adjacent to the imaged cross-section, 
confirmed that the aorta contained lipid rich plaques in the 
intimal layer (FIG. 36C). 
To observe the temperature dependent PA response, the 
temperature of the artery was changed from 38°C. to 17.5°C. 
three times, and PA responses from areas with high PA signal 
were analyzed. Specifically, four regions within the plaque 
and the periadventitial sections were identified and PA signals 
within these regions were averaged. The amplitude of PA 
signal was then normalized to the maximum amplitude and 
plotted versus temperature (FIG. 36D). Interestingly, the PA 
amplitude from periadventitial regions does not change and 
remained relatively constant with temperature, while the PA 
amplitude from plaques decreased with increasing tempera 
ture. The different trends of the PA amplitude demonstrates 
that the Grüneisen parameters for lipid in plaques and tissues 
in the periadventitial region have different temperature 
dependencies and, therefore, Suggests that lipid in plaques 
may be differentiated based on the tWPA imaging. 
Using IVPA data obtained at 25° C. and 38°C., a finite 
difference map was calculated based on Equation 4 and a 
tIVPA image was generated. The regions with decreasing PA 
amplitude versus temperature (0.4/13<D,<0.95/13) were 
colored orange, and displayed over the co-registered IVUS 
image (FIG.37A). As shown in the tIVPA image (FIG.37A), 
the PA responses from plaque regions showed consistently 
decreasing PA amplitude with temperature while the PA 
response from the periadventitial regions was different. 
Spectroscopic IVPA (sIVPA) imaging at the same cross 
section of the aorta was performed within 1210-1230 nm 
wavelength range. Similar to tVPA imaging, SIVPA imaging 
of lipid also successfully delineated lipid-rich regions in the 
arterial wall (FIG. 37B), confirming that lipid regions in the 
tIVPA image reflected lipid deposits inside the plaque. Inter 
estingly, compared to the tIVPA image, sIVPA image showed 
more lipid constituents in the periadventitial layer of the 
aorta. This difference indicates that although the lipid depos 
its in plaques and the periadventitial fat have similar optical 
properties, their Grüneisen parameter and, therefore, tem 
perature dependent PA response are different. 
To further investigate the differences of temperature 
dependent PA responses between lipid in plaques and lipid in 
adipose tissue, a sample of rabbit abdominal fat was imaged 
with the combined IVUS/IVPA imaging system (FIG. 35) by 
placing the tissue sample between the optical fiber and the 
single element IVUS catheter. PA signals were acquired at 
various temperatures at 1210 nm wavelength and normalized 
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to the maximum of the amplitude of PA signal. As shown in 
FIG. 38, the PA amplitude increases slightly within 22°C. to 
38° C. temperature range. Such a trend is opposite to the 
temperature dependence of the PA signal generated by lipid 
deposits in the plaques (FIG. 36D, red line), therefore con 
firming that adipose tissue has a different temperature depen 
dent PA response compared to lipid in plaques. 
Discussion 
tIVPA imaging can be used to differentiate tissues, in par 
ticular, lipid in atherosclerotic plaques and adipose tissue. 
With increasing tissue temperature, the PA amplitude of lipid 
in plaques decreased while the PA amplitude of lipid in peri 
adventitial and abdominal fat remained relatively constant 
within 20-38°C. temperature range. The different trends of 
the PA responses indicated that the Grüneisen parameter of 
lipids from various regions of body have unique temperature 
dependences. These dependences may result from differ 
ences in tissue composition. Adipose tissues mainly consist of 
triglyceride, whereas lipid deposits in atherosclerotic plaques 
originate from LDL particles having a low triglyceride con 
centration, but a high concentration of cholesterol and cho 
lesterol esters. The difference in triglyceride concentration 
may be the source of tIVPA contrast. 
Various factors such as depth- and wavelength-dependent 
fluence distribution, the Small displacement of aorta sample 
between different cross-sectional scans, and the variability in 
acoustic pressure and the sensitivity of the IVUS imaging 
catheter can influence the amplitude of the PA signal. How 
ever, these factors do not affect significantly the temperature 
dependence of the PA response and, therefore, the contrast in 
tIVPA images. 
In clinical practice, the decrease or increase of the tempera 
ture of the blood vessel wall may be induced by flushing low 
temperature fluid, inflating a balloon catheter filled with low 
temperature fluid, or irradiating the artery wall with laser 
light, ultrasound or microwaves. Thermal PA imaging of lipid 
can also be applied to image Superficial vessels such as 
carotid arteries. Finally, thermal PA imaging may also be 
applied to cancer diagnosis and imaging of other pathologies 
where lipid plays an important role in disease formation and 
progression. 
In this example, IVPA imaging was performed ex vivo on 
an atherosclerotic rabbit artery at different temperatures. Dif 
ferent temperature dependencies of PA responses were found 
in lipid and periadventitial fat. Based on the thermal PA 
responses, thermal intravascular photoacoustic (tIVPA) 
imaging was introduced to differentiate lipid in atheroscle 
rotic plaques. The advantage oft|VPA imaging is that it could 
be performed using an IVPA imaging system operating at a 
single wavelength. More importantly, tVPA imaging has the 
potential to differentiate lipids that have the same optical 
absorption property and, therefore, may not be distinguish 
able using conventional photoacoustic imaging approaches. 
Therefore, the present invention is well adapted to attain 
the ends and advantages mentioned as well as those that are 
inherent therein. The particular embodiments disclosed 
above are illustrative only, as the present invention may be 
modified and practiced in different but equivalent manners 
apparent to those skilled in the art having the benefit of the 
teachings herein. Furthermore, no limitations are intended to 
the details of construction or design herein shown, other than 
as described in the claims below. It is therefore evident that 
the particular illustrative embodiments disclosed above may 
be altered or modified and all such variations are considered 
within the scope and spirit of the present invention. While 
compositions and methods are described in terms of "com 














steps, the compositions and methods can also “consist essen 
tially of or “consist of the various components and steps. 
All numbers and ranges disclosed above may vary by some 
amount. Whenever a numerical range with a lower limit and 
an upper limit is disclosed, any number and any included 
range falling within the range is specifically disclosed. In 
particular, every range of values (of the form, “from about a to 
about b,” or, equivalently, “from approximately a to b,” or, 
equivalently, “from approximately a-b') disclosed herein is 
to be understood to set forth every number and range encom 
passed within the broader range of values. Also, the terms in 
the claims have their plain, ordinary meaning unless other 
wise explicitly and clearly defined by the patentee. Moreover, 
the indefinite articles 'a' or “an as used in the claims, are 
defined herein to mean one or more than one of the element 
that it introduces. If there is any conflict in the usages of a 
word or term in this specification and one or more patent or 
other documents that may be incorporated herein by refer 
ence, the definitions that are consistent with this specification 
should be adopted. 
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What is claimed is: 
1. A method comprising: 
exposing at least a portion of a sample comprising a metal 
object to electromagnetic radiation so as to generate an 
acoustic response; 
detecting the acoustic response with an acoustic sensor, 
generating a photoacoustic image of at least the portion of 
the sample comprising the metal object based on the 
acoustic response detected by the acoustic sensor, 
exposing at least a portion of the sample comprising the 
metal object to an acoustic Sound wave so as to generate 
an echo; 
detecting the echo with the acoustic sensor, and 
generating an ultrasound image of at least the portion of the 
sample comprising the metal object based on the echo 
detected by the acoustic sensor. 
2. The method of claim 1 further comprising determining 
the location or positioning of the metal object within the 
sample by using an overlay of the photoacoustic image and 
the ultrasound image. 
3. The method of claim 2 further comprising determining 
the composition of the biological tissue using the photoacous 
tic enhancement effect of the Grüneisen coefficient. 
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4. The method of claim 1 wherein the sample comprises 
biological tissue. 
5. The method of claim 4 further comprising at least par 
tially determining the composition of the biological tissue 
proximate to at least a portion of the metal object based on the 
acoustic response detected by the acoustic sensor. 
6. The method of claim 1 wherein the metal object com 
prises at least one metal object selected from the group con 
sisting of a coronary artery stent, a needle, a brachytherapy 
seed, a Surgical Staple and an orthopedic implant. 
7. The method of claim 1 wherein exposing at least a 
portion of the sample comprising the metal object to electro 
magnetic radiation comprises exposing at least a portion of 
the sample to a pulsed laser. 
8. The method of claim 7 comprising exposing the sample 
to pulses of electromagnetic radiation from the pulsed laser, 
the pulses having a duration of 1 nanoseconds to 1000 ns. 
9. The method of claim 1 wherein the electromagnetic 
radiation has a wavelength of approximately 808 nanometers 
or approximately 1064 nanometers. 
10. The method of claim 1 further comprising: 
exposing the sample comprising the metal object to more 
than one wavelength of electromagnetic radiation so as 
to generate a series of acoustic responses; 
detecting the series of acoustic responses with the acoustic 
sensor; and 
relating the series of acoustic responses to the optical 






11. The method of claim 10 wherein the more than one 
wavelength of electromagnetic radiation comprises at least 
two different wavelengths from 500 to 1200 nanometers. 
12. The method of claim 1 wherein the acoustic sensor 
comprises an ultrasonic transducer. 
13. The method of claim 1 wherein the metal object com 
prises a coating that alters a thermodynamic or optical prop 
erty of the metal object so as to enhance the acoustic response 
generated when the metal object is exposed to electromag 
netic radiation. 
14. The method of claim 13 wherein the coating comprises 
at least one selected from the group consisting of silica, gold, 
metal nanoparticles, and metal nanoparticles coated in silica. 
15. The method of claim 1 wherein the method occurs in 
real time. 
16. The method of claim 1 wherein the electromagnetic 
radiation has a wavelength of approximately 500 nanometers 
or approximately 1200 nanometers. 
17. The method of claim 1 wherein the electromagnetic 
radiation has a wavelength of approximately 700 nanometers 
or approximately 1100 nanometers. 
18. The method of claim 1 wherein all exposing and detect 
ing steps are carried out using an intravascular ultrasound 
(IVUS)/intravascular photoacoustic (IVPA) imaging device. 
19. The method of claim 1 wherein the IVUS/IVPA imag 
ing device is a catheter-based imaging device. 
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